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FH  factor H 
FHL-1  factor H-like protein 1 
FITC  fluorescein isothiocyanate 
FSC  forward scatter  
GEI  genomic island 
GlcN I  glucosamine residue I 
GlcN II glucosamine residue II 
HGT  horizontal gene transfer 
HUS  haemolytic uremic syndrome 
IPEC  intestinal pathogenic E. coli 
kDa  kilodalton (atomic mass unit) 
Kdo  α-3-deoxy-ᴅ-manno-oct-2-ulosonic acid or 2-keto-3-deoxyoctulosonic acid 
Ko  ᴅ-glycero-ᴅ-talo-oct-2-ulosonic acid  
LB  Luria-Bertani (liquid medium) 
LP  long-pass 
LPS  lipopolysaccharide 
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LT  heat-labile enterotoxins of ETEC strains 
MAC  membrane attack complex 
MASP-1 MBL-associated serine protease 1 
MASP-2 MBL-associated serine protease 2 
MBL  mannan-binding lectin 
MCP  membrane cofactor protein 
MPGN2 membranoproliferative glomerulonephritis type II 
NHS  normal human serum 
NLR  NOD-like receptor 
OmpX  outer membrane protein X 
OS  oligosaccharide 
PAI  pathogenicity-associated island 
PAMP  pathogen associated molecular pattern 
PAS  periodic acid-Schiff 
PCR  polymerase chain reaction 
PD  photodiode 
PE  phycoerythrin 
PerCP  peridinin chlorophyll protein complex 
PI  propidium jodide dye 
PMT  photomultiplier tube 
PRR  pattern recognition receptor 
RCA  regulators of complement activation 
Rck  resistance to complement-mediated killing 
SCR  short consensus repeat 
SDS-PAGE sodium dodecyl sulfate - polyacrylamide gel electrophoresis 
SP  short-pass 
SSC   side scatter  
ST  heat-stabile enterotoxin of ETEC strain 
Stx  Shiga toxin 
TBE  Tris/Borate/EDTA 
TCC  terminal complement complex 
TcpC  Toll/interleukin-1 receptor domain containing protein 
TIR  Toll/interleukin-1 receptor 
TLR  Toll-like receptor 
TO  thiazole orange dye 
VAG  virulence associated gene 
VF  virulence factor 
VT   verocytotoxin 
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1 INTRODUCTION 
The bacterium Escherichia coli (E. coli) was discovered by Theodor Escherich in 
1885. It is known as one of the most studied microorganisms in the field of 
microbiology. It is part of the normal intestinal microbiota in humans and other 
warm-blooded animals. Usually, it has a mutualistic relationship with its host, but 
some E. coli strains have acquired specific virulence factors and can cause a variety 
of infections. 
 
There are three different levels of host’s defence against invading microbes i) 
mechanical, chemical and microbial barriers, ii) innate immunity and iii) acquired 
immunity. All three levels cooperate in complex interactions. These interactions are 
enabled via cytokines, small proteins (25 kDa) that function as mediators of the 
immune system. The field of immunology is complex due to vastly different 
interactions of the immune system with pathogens and other foreign agents. The 
microorganisms are constantly evolving and the immune system has to adapt to those 
changes. This contributes to further complexity of interactions. Pathogens are also 
becoming more and more sophisticated in avoiding the host immune responses. One 
example is, for instance, so-called “mimicking” where bacteria present themselves to 
immune system with special molecules that are also found on host cells (as a 
protection against autoimmune reactions).  
 
The key part of innate immunity is the complement system, whose activation results 
in an end product called membrane attack complex (MAC). MAC can cause direct 
lysis of the cells in the case of Gram-negative bacteria. The focus in this master 
thesis was on complement system and bacteria E. coli. The interdisciplinary and 
multidisciplinary approach was applied in the research with the cooperation of three 
different laboratories in the fields of microbiology, immunology and molecular 
biology. 
1.1 AIM OF THE THESIS 
1.1.1 Objectives 
The purpose of the thesis was to determine the lipopolysaccharide (LPS) profile of 
the studied strains and to study the complement immune response triggered by 
healthy people's gut microbiota E. coli strains possessing known extraintestinal 
pathogenic E. coli (ExPEC) virulence-associated genes (VAG). 
1.1.2 Hypotheses 
The following hypotheses were set: 
 LPS profile of the studied E. coli strains correlates with the strength of the 
immune response 
 E. coli strains from the gut microbiota of healthy humans that possess VAGs 
are capable of triggering the host's immune system 
 some E. coli strains are able to avoid the immune system by binding specific 
complement factor H  
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2 LITERATURE REVIEW 
2.1 Escherichia coli  
Escherichia coli is a Gram-negative motile facultative anaerobic coliform bacterium 
(Andlovic, 2002). E. coli is part of the normal intestinal microbiota in humans and 
other mammals. In the mammalian colon E. coli inhabits the niche of the mucous 
layer, where E. coli comprises the most abundant facultative anaerobe of the 
intestinal microbiota (Kaper et al., 2004). It is a very versatile and diverse species in 
the family Enterobacteriaceae (Lukjancenko et al., 2010). Virulent E. coli strains 
cause intestinal and extraintestinal infections in humans and animals. Certain E. coli 
serotypes were associated with virulent strains. Serotyping of E. coli strains is based 
on somatic (O), capsular (K) and flagellar antigens (H). Somatic antigens are 
lipopolysaccharides (endotoxin) on the bacterial surface (Andlovic, 2002). 
 
E. coli strains are classified into 3 major groups on the basis of genetic and clinical 
criteria:  
 commensal E. coli strains,  
 intestinal pathogenic (also enteric or diarrheagenic) E. coli (IPEC) strains and  
 extraintestinal pathogenic E. coli (ExPEC) strains (Russo and Johnson, 2000).  
 
The differences in the clinical manifestation of these three groups are seen in Table 1 
(adapted from Johnson and Russo, 2002). Commensal strains are adapted for 
peaceful coexistence with the host and usually do not cause disease. They lack 
specific virulence traits that are present in intestinal and extraintestinal pathogenic 
strains of E. coli (Russo and Johnson, 2000). But a combination of genes encoding 
different virulence factors can convert commensal E. coli to pathogenic E. coli 
(Kaper et al., 2005). 
Table 1: Differences in the pathogenesis of the three major groups of E. coli (semiquantitative 
scale; - absent, +++ maximal) (adapted from Johnson and Russo, 2002). 
Preglednica 1: Razlike v patogenezi treh glavnih skupin E. coli (semikvantitativna skala; - odsotno, 
+++ maksimalno) (povzeto po Johnson in Russo, 2002). 
E. coli pathotypic group 
Clinical manifestation 
Asymptomatic 
intestinal 
colonization 
Diarrhea 
Extraintestinal 
infection 
Commensal E. coli +++ ˗ + 
Intestinal pathogenic 
(enteric or diarrheagenic) 
E. coli (IPEC) 
˗ +++ ˗ 
Extraintestinal pathogenic 
E. coli (ExPEC) 
+ ˗ +++ 
 
ExPEC strains can be, based on the site of infection, classified as uropathogenic E. 
coli (UPEC), meningitis associated E. coli (MNEC) and sepsis-causing E. coli 
(SEPEC) (Russo and Johnson, 2000; Johnson and Russo, 2002; Köhler and Dobrindt, 
2011). 
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2.1.1 Phylogenetic groups and virulence factors of E. coli 
E. coli is classified into different phylogenetic lineages. Many of the ExPEC strains 
belong to the B2 phylogenetic group, which shows the highest diversity in the gene 
content (Ochman and Selander, 1984). The connection between ExPEC strains and 
phylogenetic group B2 has been confirmed by several studies. On the other hand, 
commensal strains belong mostly to phylogenetic group A and B1 (Branger et al., 
2005).  
 
Virulence potential depends on the number and type of virulence factors, the 
inoculum size and the presence of copathogens (Russo and Johnson, 2000).  
 
A standard set of virulence factors and their virulence-associated genes (Table 2) 
were identified among ExPEC strains. They belong to different functional categories 
like adhesins, invasins, iron acquisition mechanisms, toxins and protectins (Kohler 
and Dobrindt, 2011; Starčič Erjavec and Žgur-Bertok, 2015). 
Table 2: A standard set of virulence factors identified among ExPEC (Starčič Erjavec and Žgur 
Bertok, 2014; Kohler and Dobrindt, 2011). 
Preglednica 2: Standardni set virulentnih dejavnikov sevov ExPEC (Starčič Erjavec in Žgur Bertok, 
2014; Kohler in Dobrindt, 2011). 
Functional 
category 
Virulence factors Most commonly 
tested VAGs 
Adhesins Type 1 fimbriae (Fim) 
P fimbriae (Pap/Prf) 
S/F1C fimbriae (Sfa/Foc) 
N-acetyl D-glucosamine-specific fimbriae (Gaf) 
M-agglutinin (Bma) 
Bifunctional enterobactin receptor/adhesin (Iha) 
Afimbrial adhesin (Afa) 
fimH 
papC, papG 
sfa/focDE 
gafD 
bmaE 
iha 
afa/draBC 
Invasins Invasion of brain endothelium (IbeA) ibeA 
Iron 
acquisition 
mechanisms 
Aerobactin (Iuc) 
Yersiniabactin (Ybt) 
Salmochelin (Iro) 
Siderophore receptor IreA 
Temperature-sensitive hemagglutinin (Tsh) - in birds; 
Hemoglobin protease (Hbp) - in humans 
Periplasmic iron-binding protein (SitA) 
iucD, iutA 
fyuA, irp2 
iroCD, iroN 
ireA 
tsh, hbp 
 
sitA 
Toxins alpha-Hemolysin (HlyA) 
Cytotoxic necrotizing factor 1 (CNF-1) 
Cytolethal distending toxin IV (CDT 1) 
Uropathogenic specific protein (Usp) 
Colibactin (Clb) 
Serine protease autotransporters Sat, Pic 
hlyA 
cnf1 
cdtB 
usp 
clbAQ 
sat, picU 
Protectins Group II capsule incl. K1 capsule 
Conjugal transfer surface exclusion protein (TraT) 
Outer membrane protease T (OmpT) 
Increased serum survival (Iss) 
Suppression of innate immunity (Toll/interleukin-1 
receptor domain-containing protein Tcp) 
Colicin V (Cva) 
kpsMT II 
traT 
 
ompT, APEC-ompT 
iss 
tcpC 
 
cvaC 
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Adherence factors and exotoxins are the most important virulence-associated 
properties of E. coli that can directly interact with the epithelial cells (Mainil, 2013). 
Adhesins enable colonization of the host. Bacteria can posses either fimbrial or 
afimbrial adhesins. Fimbriae are rod-like structures of 5–10 nm in diameter. Fibrillae 
are 2–4 nm in diameter and are either long and wiry or curly and flexible (Kaper et 
al., 2004). Besides the fimbrial and afimbrial adhesins, the adherence to the epithelial 
cells can be mediated also by outer membrane proteins (Mainil, 2013).  
 
Numerous E. coli toxins that damage the host are known, for instance, alpha-
hemolysin (HlyA). HlyA is a toxin that can cause cell lysis of erythrocytes and 
leukocytes. Another example of toxins are the Ibe (invasion of brain endothelial 
cells) proteins A, B and C. These are membrane proteins required for invasion of E. 
coli into the central nervous system via brain microvascular endothelial cells (Kim, 
2001).  
 
Iron is an essential nutrient for E. coli (Braun, 2001). To acquire iron E. coli 
synthesizes iron-complexing compounds, called siderophores (Braun V. and Braun 
M., 2002). Four different types of siderophore systems have been described in 
clinical E. coli isolates: enterobactin, salmochelin, yersiniabactin and aerobactin 
(Henderson et al., 2009). 
 
Protectins represent immune response evading systems, for example TcpC, which 
inhibits the Toll-like receptor (TLR) and specific internal signaling of the immune 
cells, consequently increasing the severity of infection (Cirl et al., 2008).  
 
ExPEC virulence-associated features can be also found among commensal E. coli 
(Leimbach et al., 2013). Starčič Erjavec and Žgur-Bertok (2015) showed that a 
significant percentage (around ≥ 10 %) of commensal E. coli strains isolated from 
healthy humans have, based on the presence of VAGs, a virulence potential for 
extraintestinal infections.  
 
VAGsare often found in the so called pathogenicity islands (PAIs). PAIs are 
particular large genomic regions 10‒200 kb in size that are present in the genomes of 
pathogenic strains and absent from the genomes of non-pathogenic members of the 
same or related species (Hacker and Kaper, 2000). 
2.1.1.1 Bacteriocins 
Bacteriocins are toxic proteins produced by a given strain of bacteria that are active 
against bacteria of a related species. Colicins are bacteriocins produced by E. coli. 
The producers have to possess specific immunity proteins to protect themselves from 
colicin’s toxic activity. Colins can be encoded on plasmids that can be horizontally 
transferred (Cascales et al., 2007). E. coli strains can also synthesize microcins. 
These are toxic peptides with a size of <10 kDa that are distinguished from colicins, 
which are bigger (>20 kDa) (Kastin, 2006). 
 
Bacteriocins are also important virulence factors, as they can contribute to the 
survival of a certain bacteiral strain in the host. ExPEC and fecal E. coli strains were 
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often found to harbor genes encoding synthesis of colicins and microcins 
(Micenková et al., 2014). 
2.2 LIPOPOLYSACCHARIDE (LPS) 
The cell wall of Gram˗negative bacteria is a complex multilayer structure composed 
of a cytoplasmic membrane, periplasm with peptidoglycan and outer membrane. 
Only 10% of total cell wall consists of peptidoglycan, and most of the cell wall 
represents outer membrane. The outer membrane is mainly comprised of 
lipopolysaccharide (LPS); but also phospholipids, transmembrane proteins (for 
instance porins) and lipoproteins are there. In the outer membrane also porins are 
found. Porins are proteins that function as channels for the entrance and exit of 
hydrophilic low-molecular-weight substances, hence outer membrane is relatively 
more permeable compared to cytoplasmic membrane (Madigan et al., 2009). 
 
LPS is a vigorous activator of the mammalian immune system and essential for the 
viability of the Gram-negative bacteria (Erridge et al., 2002). LPS types share some 
common principles: a phosphorylated diglucosamine backbone substituted with 
many acyl chains and at least one Kdo residue (Erridge et al., 2002). In detail, they 
consist of three distinct regions, as shown in Figure 1: lipid A, core oligosaccharide 
and O-specific chain (Caroff et al., 2002). 
 
Based on the number of O-specific chains in the LPS three different types of LPS are 
distinguished: smooth-type (S), semi-rough type (SR) and rough type (R) of LPS. 
Smooth-type is the wild-type LPS with more O-chains, semi-rough LPS has only one 
O-chain subunit and the rough-type LPS is without O-chains (Caroff et al., 2002; 
Caroff in Karibian, 2003). 
 
 
Figure 1: Schematic representation of the structure of the enterobacterial LPS (Caroff et al., 
2002). 
Slika 1: Shematska ponazoritev structure LPS pri enterobaketerijah (Caroff in sod., 2002). 
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Lipid A represents a backbone consisting of β-1,6-linked D-glucosamine (D-GlcN I 
and II) disaccharide, as schematically represented in Figure 2 (Caroff and Karibian, 
2003).  
 
 
Figure 2: Lipid A backbone and positions of substituents’ linkage (Caroff and Karibian, 2003). 
Slika 2: Ogrodje lipida A in pozicije vezave substituentov (Caroff in Karibian, 2003).  
Lipid A of E. coli is shown in Figure 3 (Caroff et al., 2002). The most frequently 
described lipid A is a hexaacylated lipid A, although penta- and tetraacylated 
molecules can be also found (Caroff and Karibian, 2003). It has been shown that the 
diphosphorylated E. coli-like hexaacylated lipid A containing two β-1-6-linked D-
glucosamines expresses the full spectrum of the endotoxic activity, while deviations 
form this structure reduce the activity of the molecule (Erridge et al., 2002). 
 
 
Figure 3: Lipid A structure of E. coli (Caroff et al., 2002). 
Slika 3: Struktura lipida A pri E. coli (Caroff in sod., 2002). 
Most of the biological activities of LPS have been associated with the lipid moiety of 
the LPS molecule.The polysaccharide moiety of LPS was associated with antigenic 
properties, solubility and charge of LPS (Caroff and Karibian, 2003). Studies showed 
that the major contributing factors to endotoxicity are the number, nature, 
arrangement, length of the acyl chains and the phosphorylation state of the 
disaccharide backbone (Erridge et al., 2002). 
 
Glucosamine residue GlcN II of the lipid A is at position C-6’ linked to the core 
region of the polysaccharide via α-3-deoxy-ᴅ-manno-oct-2-ulosonic acid or 2-keto-3-
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deoxyoctulosonic acid (Kdo) (Caroff and Karibian, 2003; Caroff et al., 2002). A 
phosphorylated diglucosamine backbone attached to at least one Kdo (or Ko) residue 
is the most highly conserved region in LPS (Erridge et at., 2002). Ko or ᴅ-glycero-ᴅ-
talo-oct-2-ulosonic acid is the Kdo analogue that some bacterial species 
(Burkholderia cepacia, Acinetobacter haemolyticus, Yersinia pestis) synthesize and 
incorporate instead of Kdo or in addition to it into their cell wall (Caroff and 
Karibian, 2003). 
 
Core oligosaccharide is divided into the more conserved inner and the variable outer 
core. Inner core is characterized by sugars, particularly Kdo and heptose. In outer 
core, there are hexose sugars (hexose region) such as glucose, galactose, N-acetyl 
galactosamine and N-acetyl glucosamine (Erridge et al., 2002).  
 
O-specific chains consist of repetitive subunits and are present only in smooth-type 
Gram-negative bacteria. Each subunit is composed of one to eight sugar units and 
there can be up to 50 identical subunits in an O-chain. The chains help the bacteria to 
escape the lytic action of the complement system, protect against numerous 
antibiotics and are responsible for the adhesion process. Moreover, they determine 
the specificity of each bacterial serotype, as they are the basis of O-chain structures 
uniqueness (Caroff and Karibian, 2003). O-chain in LPS is also referred as O-antigen 
because it is expressed on the outermost surface of the bacteria and is, therefore, the 
major antigen targeted by the immune system  (Erridge et al., 2002). 
2.2.1 Variability of the O-antigen 
LPS can activate innate and adaptive immune response. O-antigen is highly 
immunogenic and induces the production of antibodies that can activate the 
complement system. Variability of the O-antigen in the LPS plays an important role 
in infections, caused by Gram-negative bacteria, because the modifications in the 
LPS O-antigen can influence bacterial adherence, colonization and evasion. Because 
of the large variability of the O-antigen, various clones can exist within a single 
species, which offers a selective advantage for the species. Many pathogens also 
have the capability of varying their antigenic composition, as they may change the 
antigens that are attached to their surface (Reyes et al., 2012).  
 
The LPS has a negative charge and provides integrity and stability to the external 
membrane of the bacteria. Especially important is the central portion of the LPS, 
because it provides a barrier against hydrophobic antibiotics and other components, 
therefore isolates that express long LPS have intrinsic resistance to these factors 
(Reyes et al., 2012).   
2.2.2 Core oligosaccharide types in E. coli 
Amor et al. (2000) developed a PCR based LPS core typing system for E. coli 
isolates based on the waa loci responsible for core oligosaccharide (OS) 
biosynthesis. The outer region of the core OS is more variable than the inner core 
and there are five different core OS: R1, R2, R3, R4, and K-12. All the outer core 
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oligosaccharides share a carbohydrate backbone of three hexoses and two side chain 
residues, but their distribution and linkage can vary (Amor et al., 2000). 
 
The distribution of all five core OS types among strains of the ECOR collection is as 
follows: in the phylogenetic group A occur strains all five types, although there is a 
limited number of isolates with the K-12 type. Among the ECOR strains belonging 
to the phylogenetic group E, R1, R2, R3 and R4 core types can be found. ECOR 
strains belonging to the B1 phylogentic group have primary R1 and R3 types, and the 
strains of the phylogenetic groups B2 and D have only R1 type core OSs (Amor et 
al., 2000). As already mentioned before, ECOR phylogroups B2 and D are strongly 
connected with ExPEC strains (Boyd and Hartl, 1998; Picard et al., 1999; Branger et 
al., 2005). 
2.2.3 Immune response to LPS 
Monocytes/macrophages and also dendritic cells are the target cells highly sensitive 
to LPS stimulation (Caroff et al., 2002). It had been recognized that CD14 is the 
macrophage receptor,which identifies LPS of Gram-negative bacteria (Kaufmann, 
2014). But CD14 is a GPI anchored protein, which lacks a transmembrane domain 
for facilitation of intracellular signaling. In addition, it has been discovered that 
receptor molecules responsible for the recognition of the LPS are not only proteins 
CD14 but also proteins of the TLR-4/MD-2 complex. Possible mechanisms for LPS 
recognition and intracellular signaling by this complex have been proposed (Erridge 
et al., 2002).  
 
As already mentioned, the high toxicity of the LPS can be explained by its structure. 
Molecules displaying an acylation pattern similar to that of E. coli are the ones 
optimally recognized by human monocytes (Erridge et al., 2002). 
2.2.4 Smooth and rough E. coli strains 
According to the literature smooth strains are more serum-resistant and rough strains 
are serum sensitive, although both can activate the complement system. O-antigen 
polysaccharide side chains protect the bacteria by activating complement away from 
sensitive membrane target sites on the outer membrane or by blocking antibody 
binding sites (Miajlovic and Smith, 2014; Johnson, 1991) Another important factor is 
also membrane fluidity, which is associated with smooth-type lipopolysaccharide 
and can protect against effective membrane attack compelx (MAC) insertion 
(Johnson, 1991). Also some certain virulence factors genes (traT and iss) are known 
that can prevent MAC from functioning normally even if it reaches the outer 
membrane (Johnson, 1991). 
2.3 INNATE IMMUNE SYSTEM 
The human immune system is divided into innate (unspecific) and acquired (specific 
or adaptive) immunity. Innate immunity includes different cells and processes such 
as phagocytosis by white blood cells and cells of the tissue macrophage system, 
destruction by the acid secretion and digestive enzymes in the alimentary tract, 
resistance of the skin and presence of certain chemical compounds in the blood that 
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attach to foreign microorganisms and toxins (lysozymes, basic polypeptides, the 
complement system, natural killer lymphocytes) (Guyton and Hall, 2006). Thus, 
immune system consists of two complementary systems: humoral immune system 
directed against bacterial infections and viruses (those found in the body fluids) and 
cellular immune system which destroys cells infected by viruses, parasites and 
foreign tissues (Lehninger et al., 2005). Although the innate and adaptive immune 
responses are fundamentally different in their mechanisms of action, synergy 
(supplementation and cooperation) enables an intact and fully effective immune 
response (Chaplin, 2006).    
 
The simplest evolutionary cells are phagocytes (most important neutrophils, 
monocytes, macrophages and dendritic cells), which engulf and digest the offending 
agent into sugars, amino acids, and fats. Phagocytes have pattern recognition 
receptors (PRR) on their surface that bind with conservative molecular structures on 
the surface of the pathogens called pathogen-associated molecular patterns (PAMP). 
PRRs are Toll-like receptors (TLR), type C lectins and intracellular NOD-like 
receptors (NLR). The recognition and phagocytosis of the foreign agent are usually 
not enough for its elimination. The connection between unspecific and specific 
immunity via antigen presenting cells (APCs) is vital for foreing agent elimination 
(Ihan and Kopitar, 2010).  
 
The cellular innate immune system includes following cells: 
- monocytes and macrophages, 
- polymorphonuclear granulocytes (neutrophils, eosinophils, and basophils), 
- mast cells, 
- dendritic cells and 
- natural killer cells (Schütt and Bröker, 2011). 
 
Besides cellular immune system, there is a humoral innate immune system consisting 
of the complement system, proteins of acute phase and different cytokines.  
2.3.1 Complement system 
The complement system is part of the innate immune response. It is composed of 
various and numerous proteins, which can be found in body fluids or on the surface 
of the cells. The main source of the complement system is liver. Complement system 
activates in a cascade way and results in the formation of a lytic complex, which 
degrades the bacterial cell membrane, causing its lysis (Ihan and Kotnik, 2002). The 
activation of the complement system enables the amplification of the initial response 
with a series of sequential enzyme reactions (Schwaeble et al., 2013). 
 
Regulators of complement activation (RCA) ensure that any action of complement 
system on host cells is either prevented or inhibited. This is why excessive 
complement activation on host cells can lead to serious complications and various 
diseases. These structurally similar complement regulators are complement receptor 
1 (CR1), factor H (FH), factor H-like protein (FHL-1), C4-binding protein (C4BP), 
decay accelerating factor (DAF) and membrane cofactor protein (MCP). The purpose 
of the RCAs is either to destabilize the C3 convertase (decay accelerating activity) or 
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promote the factor-I-mediated degradation of C3b to iC3b (cofactor activity) 
(Lambris et al., 2008). 
 
Three different ways of activation of the complement system are known: the classical 
complement pathway, the alternative complement pathway, and the lectin 
complement pathway, as shown in figure 4 (Schwaeble et al., 2013). 
 
The activation of the classical pathway is caused by immune complexes (antibodies 
bound to antigen), meanwhile, the alternative pathway activates when a pathogen 
enters the organism; the activation is not linked to specific antibodies (Ihan and 
Kotnik, 2002). Lectin pathway, which is antibody independent variant of the 
classical pathway, is triggered when microbial carbohydrates interact with mannose-
binding protein (Schwaeble et al., 2013). 
 
 
Figure 4: Three different pathways of the complement system activation (Schwaeble et al., 
2013). 
Slika 4: Tri različne poti aktivacije komplementnega sistema (Schwaeble in sod., 2013). 
2.3.1.1 Alternative pathway 
It is important to have a spontaneous hydrolysis of the component C3 in blood serum 
to initiate the alternative pathway. C3 forms C3(H2O) and consequently C3(H2O)B 
with factor B. Factor B is cleaved by factor D into fragments Ba and Bb; Bb remains 
attached to the complex. The complex C3(H2O)Bb is a C3 convertase, which cleaves 
C3 into C3a and C3b (Schwaeble et al., 2013). C3b binds to the surface of pathogens 
where it can bind to another molecule of factor B and forms a new C3 convertase 
C3bBb (Carroll and Sim, 2011). After further splitting of C3, another molecule of 
C3b is added to the C3 convertase, which results in the formation of C5 convertase 
C3bBb3b. Finally, C5 convertase splits C5 into C5a and C5b, which leads to the 
generation of MAC  (Schwaeble et al., 2013).  
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2.3.1.2 Classical pathway 
The activation of the classical complement pathway triggers particle C1. It is a 790 
kDa complex composed of C1q recognition protein and a heterotetramer C1r2s2 
(Schwaeble et al., 2013). On one hand, the activation of the classical pathway can be 
triggered directly by binding to a target surface, on the other hand, indirectly by 
binding of C1q to antibodies IgM, IgG1, IgG2 and IgG3 deposited on the target 
surface (Schwaeble et al., 2013; Arlaud et al., 2002). Conformational change of 
particle C1q leads to cleavage of C1s, which in turn cleaves C4 and C2, resulting in 
in the formation C4b2a or C3 convertase (Arlaud et al., 2002; Carroll and Sim, 
2011).  
2.3.1.3 Lectin pathway 
It is proposed that the lectin pathway or lectin-like pathway is the oldest pathway of 
the complement system (Dodds, 2002). The main targets of this pathway are mannan 
residues on the surface of microorganisms. Mannan-binding lectins (MBLs) bind to 
these residue and activate the pathway. In addition, two serine proteases – MASP-1 
and MASP-2 (MBL-associated serine protease) bind to MBL and cleave the particles 
C4 and C2. As a result, convertase C3 is made, which is identical to convertase C3 
made by classical pathway (Kotnik, 2010). 
2.3.1.4 Membrane attack complex (MAC) 
In the first steps of the complement system, C3 and C5 convertases are made. C3 
convertase C4b2a made by lectin or classical complement pathway corresponds to 
C3 convertase C3Bb made by alternative complement pathway, as shown in Figure 
4. And the same holds true for the C5 convertase C4b2a3b made by lectin or 
classical pathway, corresponding to C5 convertase C3bBb3b made by alternative 
pathway (Schwaeble et al., 2013). 
 
The terminal complement complex (TCC) is called MAC (membrane attack 
complex) or particle C5b-9. After C5 convertase degrades C5 into C5a and C5b, C6 
binds to C5b, and afterward C7, C8 and finally C9. This complex constructs a 
cylindrical pore with 10 nm diameter into the cell membrane, which causes the efflux 
of electrolytes and consequently lysis of the cell (Ihan and Kotnik, 2002). 
2.3.2 Complement evasion by pathogens 
Microbes use several strategies to evade the host immune responses (Lambris et al., 
2008). The successful strategies are the recruitment of mimicking complement 
regulators, the modulation or inhibition of complement proteins by direct 
interactions, and inactivation by enzymatic degradation. Immune evasion strategies 
are focused on complement system because it is the center of the innate immunity 
and the first line of defense against pathogenic microorganisms (Lambris et al., 
2008). In the master thesis, we focused on the recruitment of complement regulator 
factor H, which is an important virulence factor for some bacteria. 
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2.3.2.1 Complement factor H (CFH)  
Factor H is a single polypeptide chain plasma glycoprotein with molecular weight of 
155 kDa. It is a regulatory protein in the alternative complement pathway and it 
regulates complement both in fluid-phase and on cellular surfaces (Rodríguez De 
Córdoba et al., 2004). It binds to particle C3b, in order to prevent the binding of 
factor B and the formation of C3 convertase (C3bBb) via the alternative pathway. 
Factor H has a high affinity to the particle C3b, which is bound to body’s own cells 
and low affinity to the bacterial cells, where factor B can bind, causing the formation 
of the lytic complex. Factor H is also a cofactor for factor I, which degrades C3b to 
iC3b and finally to C3d, thus also preventing the formation of C3 convertase. And it 
also works as decay accelerating factor, which accelerates degradation of C3bBb 
(Pouw et al., 2015). To sum up, all the regulating mechanisms of factor H inhibit the 
activation of the complement system via the alternative pathway. Therefore, if the 
microorganism binds complement factor H, it can avoid the attack of the complement 
system. 
 
Complement factor H is a member of the CFH protein family. Besides complement 
factor H, this family includes complement regulator CFH-like protein 1 (CFHL1) 
and five CFH-related proteins (CFHR1, CFHR2, CFHR3, CFHR4A and CFHR4B, 
CFHR5). These proteins are produced primarily in the liver and composed of 
individually folding domains termed short consensus repeats (SCR) or complement 
control protein (CCP) modules. The genes of these proteins are found in the CFH 
gene cluster on the human chromosome 1q32 (Józsi and Zipfel, 2008). 
 
CFH is composed of 20 SCR domains with two major functional regions (Figure 5): 
the N-terminal for SCR domains (SCRs 1-4) which facilitate the decay of C3 
convertase and acts as a cofactor for factor I, and the C-terminal three SCR domains 
(SCRs 18-20) which mediate surface binding and target recognition. CFHL1 protein 
is composed of seven N-terminal domains found in CFH and a C-terminal four 
amino acids extension. For this reason, it has a similar complement regulatory 
activity as CFH. The other CFHR proteins have four to nine SCR domains that also 
show similarities to SCRs of CFH. Genetic mutations in the CFH gene cluster are 
associated with several human diseases such as atypical hemolytic uremic syndrome 
(aHUS), membranoproliferative glomerulonephritis type II (MPGN2) and age-
related macular degeneration (AMD) (Józsi and Zipfel, 2008). 
 
 
Figure 5: The structure of the complement factor H and CFH-like protein binding sites (Józsi 
and Zipfel, 2008).  
Slika 5: Struktura faktorja H in vezavnih mest CFH-podobnega proteina 1 (Józsi in Zipfel, 2008).  
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RCA recruitment is common in bacteria, but it has also been described for viruses, 
fungi, and parasites (Lambris et al., 2008). Lots of different pathogenic 
microorganisms have been identified to use an evasion strategy of binding the host 
regulator factor H and FHL-1. Some of the microorganisms are also Borrelia 
burgdorferi, Candida albicans, Echinococcus granulosus, Neisseria gonorrhoeae, 
Onhocerca volvulus, Streptococcus pneumoniae and Yersinia enterocolitica 
(Rodríguez De Córdoba et al., 2004). 
2.4 SODIUM DODECYL SULFATE - POLYACRYLAMIDE GEL 
ELECTROPHORESIS (SDS-PAGE) 
Depending on the pH of the solvent and the amino acid composition, proteins have a 
net positive, neutral or negative charge. If proteins are put into an electric field, they 
migrate according to their charge, size and shape. This technique is known as 
electrophoresis (Alberts et al., 2008).  
 
SDS-PAGE is a specialized type of electrophoresis (Figure 6) for determining the 
size and subunit composition of a protein. In this technique a special type of a highly 
cross-linked porous gel of polyacrylamide is used as an inert matrix through which 
proteins migrate. The proteins are put into a powerful negatively charged detergent 
sodium dodecyl sulphate (SDS) that binds to hydrophobic regions of the proteins, 
causing them to unfold into polypeptide chains. Also a reducing agent such as β-
mercaptoethanol is added to break any S-S lineages in the proteins. So, this technique 
enables the analysis of individual proteins. Because of negatively charged detergent 
molecules, the proteins are also negatively charged (irrespective of their net charge) 
and migrate to the positive electrode in the polyacrylamide gel when the voltage is 
applied. Large proteins are retarded more severely, because of the gel, which acts as 
a molecular sieve. Due to these principles, the result of the electrophoresis is a series 
of a discrete protein bands arranged in order of molecular weight. The proteins are 
detected by staining the gel with a particular dye as Coomassie Brilliant Blue. For 
smaller proteins the gels are treated with silver stain, which enables the detection of 
as little as 10 ng of proteins. Each protein appears as a sharp, dye-stained band; if a 
band is broadened, it contains too much protein (Alberts et al., 2008). The sensitivity 
of the silver stain is comparable to that of autoradiography. The silver stain is also 
500 times more sensitive than PAS (periodic acid-Schiff) stain. Proteins and 
carbohydrates are stained with silver stain, therefore glycoproteins such is LPS are 
also stained with high sensitivity (Tsai and Frasch, 1982).  
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Figure 6: A schematic drawing of an SDS-PAGE electrophoresis apparatus (Alberts et al., 
2008). 
Slika 6: Shematski prikaz aparata za SDS-PAGE elektroforezo (Alberts in sod., 2008). 
SDS-PAGE followed by silver staining is also used for polysaccharide analysis (Tsai 
and Frasch, 1982). Because O-chains occur in different lengths in a certain 
microorganism, the result after SDS-PAGE silver stain is a ladder-like profile with 
rungs (bands). The bands represent the number of repeating units present in the O-
polysaccharides and spacing between the bands reflects the size of the repeating unit 
(Goldman and Leive, 1980; Palva and Mäkelä, 1980; Tsai and Frasch, 1982). The 
fastest migrating band (the lowest band on the stained gel) is LPS without O-chain 
(R-LPS), the second band represents the core-plus-one repeating unit (SR-LPS) and 
so on to S-LPS (all the other highest bands on the stained gel) (Tsai and Frasch, 
1982; Fomsgaard et al., 1990).   
2.5 FLOW CYTOMETRY 
Flow cytometry is an important method for analyzing physical and chemical 
characteristics of different particles in small quantities like cells, antigens and 
antibodies. The main components of the flow cytometer are: 
 light source (laser beam), 
 cytometry chamber with optical system of lenses, mirrors and filters, 
 electronics for the transformation of light impulses to electrical and digital 
signals, 
 computer system for the analysis, coordination and regulation of the whole 
system (Ihan and Kopitar, 2010).  
 
Thus, flow cytometer is made up of three main systems: fluidics, optics and 
electronics. The fluidics transports particles in a stream to the laser beam, the optics 
consists of lasers to illuminate the particles and direct the resulting light signal to the 
detector, and electronics converts the detected light signals into electronic signals 
that can be processed by the computer. Any suspended particle 0.2‒150 µm in size is 
suitable for analysis (BD Biosciences, 2000). The cells are suspended in an isotonic 
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fluid, which passes by an electronic detection apparatus (Ihan and Kopitar, 2010). 
The light is generated by a light source, and absorbed and emitted by a fluorochrome. 
Fluorochromes are a fluorescent chemical compounds that activate at certain 
wavelength (light excitation) and re-emit light at different wavelength (light 
emission) in visible spectrum (Ihan and Kopitar, 2010). 
 
Lasers are usually a light source that gives energy in a way of photons with different 
wavelength and energy. Fluorochrome absorbs and then emits light with certain 
wavelength. Electrons in fluorochrome are excited to higher, more energetic orbitals 
and then return to ground-state or less energetic orbitals ‒ the emitted light is called 
fluorescence. Fluorochromes have absorption and emission range with certain 
wavelength maxima. For instance fluorescein isothiocyanate (FITC) absorbs light in 
the range of 460‒510 nm and fluoresces in the range of 510‒560 nm with a peak of 
530 nm (green). The difference between orbital energy levels strictly determines the 
light the fluorochrome can absorb. This light is provided by a laser in a form of a 
bright, narrow, stable light beam of well-defined color and intensity. Different lasers 
can be used as a source of light for fluorochromes excitation and use of a laser 
restricts the choice of a fluorochrome used for staining cells (Table 3). The most 
common lasers used today in flow cytometry are argon ion lasers, which emit light at 
488 nm wavelength (turquoise) and at 514 nm (green), as well as small amounts of 
ultraviolet light (Givan, 2001).  
Table 3: Different combinations of lasers and fluorochromes used in flow cytometry (Givan, 
2001). 
Preglednica 3: Različne kombinacije laserjev in fluorokromov, ki jih uporabljamo v pretočni 
citometriji (Givan, 2001). 
Laser type Wavelengths (nm) Possible fluorochromes 
Argon ion 488 Fluorescein, R-phycoerythrin, PcrCP, PE-tandems, 
EGFP, EYFP, propidium iodide, Alcxa 488, acridine 
orange 
 514 Rhodamine, propidium iodide, EYFP,  
R-phycoerythrin 
 Ultraviolet Hoechst dyes, DAPI, Indo-1, AMCA, 
 (351/364) Cascade Blue, EBFP 
Helium-neon  
(HeNe) 
 
Usually 633 Allophycocyanin, Cy5, TO-PRO-3 
Krypton ion 568 Cy3, Texas Red, Alcxa 568 
 647 Allophycocyanin, Cy5, TOPRO-3 
Red diode 635 Allophycocyanin, Cy5, TOPRO-3 
Helium-cadmium 
(HeCd) 
325 Indo-1, propidium iodide 
 442 Mithramycin, chromomycin A3, ECFP 
 
The light scattered by a cell and emitted by various cell fluorochromes provide 
signals that are detected on the photodetectors. The light emitted from fluorochromes 
will be of different colors. Dichroic mirrors than split the light beam according to 
color. At the dichroic mirrors partitioning of the light beam (signal) takes place. 
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Dichroic mirrors are short-pass (transmit light of a wavelength shorter than the 
specified value) and long-pass (transmit light of a wavelength greater than the 
specified value). Usually there is a typical two-scatter parameter plus three 
fluorescence parameter system for partitioning multicolor light as seen on Figure 7 
(Givan, 2001). 
 
In flow cytometry the signal (emitted, reflected or diffracted light) is detected by two 
scatter photodetectors: one in the direction of the light source from the laser beam 
called forward angle light scatter (parameter FALS or FSC – Forward SCatter), and 
the other perpendicular to the light source called right angle light scatter (parameter 
RALS or SSC – Side SCatter) (Ihan and Kopitar, 2010). Thus, FSC signal is present 
in the direction of the laser beam and SSC is reflected (by a 500 LP dichroic mirror) 
out of the beam path toward the first PMT tube as schematically depicted on Figure 7 
(Givan, 2001). Forward-scattered light (mostly diffracted light) is proportional to 
cell-surface area or size, and side-scattered light (mostly refracted or reflected light) 
is proportional to cell granularity or internal complexity (BD Biosciences, 2000).  
 
Filters are used at 90° to the light pass; they transmit light according to its color. A 
short-pass (SP) filter will transmit light of a wavelength less than the specified value, 
a long-pass (LP) filter will transmit light of a wavelength greater than the specified 
value, and a band-pass (BP) filter will transmit only light in a narrow wavelength 
band around the specified value. BP filters are usually used because they are the most 
specific; their characteristics are described according to the peak transmission 
wavelength and the width of the wavelength band at 50% of that peak transmission. 
Different filter and mirrors combinations are required for experiments using different 
combinations of stains (Givan, 2001).  
 
Figure 7: The schematic representation of a flow cytometry system with one 488 nm laser and 
five photodetectors (forward-scatter, side-scatter, far-red, orange and green signal) (Givan, 
2001). 
Slika 7: Shematski prikaz sistema za pretočno citometrijo z enim 488 nm laserjem in petimi 
fotodetektorji (»forward-scatter«, »side-scatter«, rdeč, oranžen in zelen signal) (Givan, 2001). 
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2.5.1 Cell viability staining 
The cells were stained with BD Cell Viability Kit, which  can be used to distinguish 
live and dead bacteria, yeasts or eukaryotic cells (BD Biosciences, 2012). The kit 
contains thiazole orange (TO) that stains live and dead cells to a varying degree, and 
propidium iodide (PI) that stains only dead cells (cells with compromised 
membrane). Depletion of a LPS with EDTA greatly facilitates TO uptake, because 
LPS can interfere with the TO uptake (Alsharif and Godfrey, 2002). Thiazole orange 
and propidium iodide bind to DNA (also RNA) in the cells. Binding usually occurs 
by intercalation of the dye into the double-stranded helical structure leading to 
enhancement in fluorescence. With the dyeing we can distinguish the overall cell 
populations from the background (meaning different impurities or debris) and 
moreover, we can distinguish live and dead cells, and also injured cells. 
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3 MATERIALS AND METHODS 
3.1 MATERIALS 
3.1.1 E. coli strains, isolated from healthy individuals 
In the master thesis we used E. coli strains isolated from fecal samples of healthy 
human donors ‒ 14 E. coli strains from the BJ collection: BJ14, BJ16, BJ17, BJ23, 
BJ27, BJ30, , BJ33, BJ34 (Figure 8), BJ51, BJ67, BJ69, BJ93, BJ95, BJ97. The E. 
coli BJ collection consists of 90 E. coli strains isolated from healthy human fecal 
samples from four different age groups (<19, 19–45, 46–64, >64 years) and is stored 
at the Chair of Molecular Genetics and Biology of Microorganisms, Department of 
Biology, Biotechnical faculty, University of Ljubljana (Jesenko, 2011). Čitar (2010) 
in her research showed that many of the BJ strains possessed ExPEC virulence-
associated genes. Appart from virulence-associated genes and the phylogenetic group 
also microcins and colicins were tested for the whole BJ strain collection.  
 
  
Figure 8: E. coli BJ34 bacterial strain on a blood agar plate (Photo: Kociper M.). 
Slika 8: Bakterijski sev E. coli BJ34 na plošči krvnega agarja (Foto: Kociper M.). 
The set of fourteen E. coli BJ strains used in this thesis was selected to represent 
genotipically different variants of E. coli from the BJ collection, some possessing a 
lot of VAGs, and some only a few VAGs. The already known data about the selected 
set of BJ strains is gathered in Table 4, Table 5 and Table 6. 
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Table 4: Phylogenetic groups, genes encoding adhezins, invasins and iron acquisition systems of 
selected E. coli BJ strains. 
Preglednica 4: Filogenetske skupine, geni z zapisi za adhezine, invazine in sisteme za privzem železa 
izbranih sevov BJ E. coli . 
E. coli strain 
and 
phylogenetic 
group 
ADHESINS 
ADHESIN 
and 
INVASIN 
IRON ACQUISITION 
papGII papGIII afa/dra sfaDE iha fimH ibeA fyuA hbp ireA iucD iroN 
BJ14 B1 0 0 0 0 0 1 0 0 0 0 0 1 
BJ16 A 0 0 0 0 0 0 0 0 0 0 0 0 
BJ17 A 0 0 0 0 0 0 0 1 0 0 0 1 
BJ23 B2 0 0 0 1 0 1 1 1 1 1 1 1 
BJ27 B2 0 0 0 1 0 1 1 1 0 0 0 1 
BJ30 B2 0 1 0 1 0 1 0 1 0 0 0 1 
BJ33 B2 0 1 0 1 0 1 0 1 0 1 0 1 
BJ34 B2 0 0 0 0 1 1 0 1 0 1 1 1 
BJ51 B2 1 0 0 0 0 1 0 1 0 1 1 1 
BJ67 B2 0 0 0 1 0 1 1 1 1 0 1 1 
BJ69 B2 0 0 0 1 1 1 0 1 0 0 1 1 
BJ93 B2 0 0 0 1 0 1 1 1 1 0 1 1 
BJ95 B2 1 0 0 0 0 1 0 1 0 1 1 1 
BJ97 B2 0 0 0 1 0 1 1 1 1 0 1 1 
Altogether 2 2 0 8 2 12 5 12 4 5 8 13 
 
Table 5: Genes encoding toxins, protectins and conjugation-associated proteins of selected E. 
coli BJ strains. 
Preglednica 5: Geni za toksine, protektine in s konjugacijo povezani geni izbranih sevov BJ E. coli. 
 
TOXINS PROTECTINS CONJUGATION 
E. coli 
strain 
hlyA usp clbAQ picU kpsMT ompT 
APEC-
ompT 
tcpC iss neuB traJ traT* 
BJ14 0 0 0 0 0 1 0 0 0 0 0 0 
BJ16 0 0 0 0 0 0 0 0 0 0 0 0 
BJ17 0 0 0 0 0 0 0 0 0 0 0 0 
BJ23 0 1 1 0 1 1 1 0 1 1 1 1 
BJ27 1 1 1 0 1 1 0 1 0 1 1 1 
BJ30 1 1 1 0 1 1 0 1 0 1 0 0 
BJ33 1 1 1 0 1 1 0 1 0 1 0 0 
BJ34 0 1 0 0 1 1 1 0 1 1 1 1 
BJ51 0 1 0 0 1 1 1 0 1 1 1 1 
BJ67 0 1 1 0 1 1 0 0 0 1 1 1 
BJ69 0 1 1 0 1 1 1 1 0 0 0 0 
BJ93 0 1 1 0 1 1 1 0 0 1 1 1 
BJ95 0 1 0 0 1 1 1 0 1 1 1 1 
BJ97 0 1 1 0 1 1 1 0 0 1 1 1 
Altogether 3 11 8 0 11 12 7 4 4 10 8 8 
*Product of the gen TraT increases serum resistance and belongs also to protectins. 
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Table 6: Genes encoding microcins and colicins of selected E. coli BJ strains. 
Preglednica 6: Geni za mikrocine in kolicine izbranih sevov BJ E. coli. 
 
MICROCINS COLICINS 
E. coli strain microcin M microcin V 
colicin 
B 
colicin 
M 
colicin 
E1 
colicin 
E7 
colicin 
la 
colicin 
ib 
colicin K 
BJ14 0 1 0 0 0 0 0 0 0 
BJ16 0 0 0 0 0 1 0 1 0 
BJ17 0 1 0 0 0 0 1 0 0 
BJ23 1 1 1 1 0 0 0 0 0 
BJ27 0 0 0 0 0 0 0 0 0 
BJ30 1 0 0 0 0 0 0 0 0 
BJ33 1 0 0 0 0 0 0 0 1 
BJ34 0 1 0 0 0 0 1 0 1 
BJ51 0 1 0 0 0 0 1 0 1 
BJ67 0 0 1 1 0 0 0 0 0 
BJ69 0 0 0 0 0 0 0 0 0 
BJ93 0 1 1 1 0 0 0 0 0 
BJ95 0 1 0 0 0 1 1 0 0 
BJ97 0 1 1 1 0 1 0 0 0 
Altogether 3 8 4 4 0 3 4 1 3 
3.1.1 E. coli strains, used as controls in performed assays 
For different assays in this thesis different positive and negative control strains were 
used. Their characteristics are taken together and presented in Table 7. The type E. 
coli strain NCTC 9001 is part of the National Collection of Type Cultures (NCTC), a 
culture collection of Public Health England. It was chosen from the collection of 
reference strains at the Division of Hygiene and Medical Microbiology, Department 
of Hygiene, Microbiology and Public Health, Medical University of Innsbruck. All 
the other strains listed in Table 7 were obtained from the collection at the 
Department of Biology, Chair of Molecular Genetics and Biology of 
Microorganisms, Biotechnical Faculty, University of Ljubljana. 
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Table 7: Control strains used in the experiments. 
Preglednica 7: Kontrolni sevi, uporabljeni pri eksperimentih. 
E. coli 
strain 
Control Significant characteristics 
Source or 
reference 
NCTC 
9001 
Positive control in 
factor H and C7 
binding 
Uropathogenic strain, part of the National 
Collection of Type Cultures 
Würzner R., 
Medical 
University of 
Innsbruck 
UPEC 
J96 
Positive control in 
factor H and C7 
binding, and O-core 
PCR 
Uropathogenic strain, R1 O-core 
(isolated from the patient with 
pyelonephritis) 
Hull et al., 1981 
MG1655 
Negative control in 
factor H and C7 
binding, and positive 
control in O-core 
PCR 
Wild-type laboratory strain of E. coli 
(RecA+), K-12 O-core (deletion of 
bacteriophage λ and F-plasmide) ‒ the 
best approximation to natural wild-type 
strain 
Blattner et al., 
1997 
DH5α 
Negative control in 
factor H and C7 
binding 
Genetically modified non-pathogenic 
laboratory strain (RecA-); more 
modifications and lower fitness 
Taylor et. al., 
1993 
536 
Positive control in 
C7 binding 
Uropathogenic strain  
(isolated form the patient with cystitis) 
Hochhut et al., 
2006 
HS24 
Positive control in 
C7 binding 
Uroseptic strain Rijavec, 2010 
HS39 
Positive control in 
C7 binding 
Uroseptic strain Rijavec, 2010 
SE15 
Negative control in 
C7 binding 
Typical commensal strain Toh et al., 2010 
MC4100 
Positive control in 
SDS-PAGE 
Smooth strain Casadaban, 1976 
DL94 
Positive control in 
SDS-PAGE 
Rough strain Lončar, 2002 
Nissle 
1917 
Positive control in 
SDS-PAGE 
Semi-rough strain 
Scaldaferri et al., 
2016 
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3.1.2 Culture media 
3.1.2.1 Liquid LB-medium 
The liquid LB-medium was prepared either consisting of 5 g of NaCl, 5 g of tryptone 
and 2.5 g of yeast extract dissolved in 500 ml distilled water or consisting of 12.5 g 
of LB Broth Miller powder dissolved in 500 ml dH2O. The medium was autoclaved 
at 121 °C for 20 min. Liquid medium was stored at 4 °C. 
3.1.2.2 Solid LB-medium 
In an Erlenmeyer flask 12.5 g of LB Broth Miller powder and 7.5 g agar were 
dissolved in 500 ml dH2O. Medium was autoclaved at 121 °C for 15 min, when 
cooled down to 55 °C  it was aseptically poured in disposable plastic Petri dishes. 
Liquid medium solidified during the night and was stored at 4 °C. 
3.1.3 Normal human serum (NHS) and antibodies for complement analyses 
Normal human serum (NHS) from the same pool of 5 different donors was used at 
Division of Hygiene and Medical Microbiology in Innsbruck. The serum pool was 
freshly prepared before usage.  
The following antibodies were used in Innsbruck: 
 
 Invitrogen complement factor H rabbit IgG antibody (PA5-24425, 
concentration Lot-specific) ‒ polyclonal rabbit IgG antibody to human 
CFH, Thermo Scientific, USA  
 
The antibody was prepared in dilution 1:50 with FACS-WASH. 
 
 allotype-specific monoclonal antibody (mAb) mouse IgG1 against human 
C7 particle ‒ WU 4-15  (Würzner et al., 1990), concentration 1 mg/ml, ‘in 
house material’, Divison of Hygiene and Medical Microbiology, 
Innsbruck 
 
The antibody was prepared in dilution 1:50 with FACS-WASH. 
 
 goat α-rabbit IgG (conjugated with Alexa Fluor 488, A11008, 
concentration 2 mg/ml) ‒ goat polyclonal secondary antibody to rabbit 
IgG, Life Technologies, USA  
 
The antibody was prepared in dilution 1:500 with FACS-WASH. 
For further analyses in Ljubljana, human serum from the same pool of 55 different 
donors was used at Institute of Microbiology and Immunology in Ljubljana. The 
serum pool was prepared in 2014.  
The following antibodies were also used in Ljubljana: 
 allotype-specific monoclonal antibody (mAb) mouse IgG1 against human 
C7 particle ‒ WU 4-15 (HM2277), concentration 1 mg/ml, Hycult 
Biotech, Netherlands 
Kociper M. Lipopolysaccharide structure and complement system response to selected Escherichia coli strains. 
   M. Sc. Thesis (Du2). Ljubljana, University of Ljubljana, Biotechnical Faculty, Academic Study in Microbiology, 2018 
 
23 
 
The antibody was prepared in dilution 1:50 with FACS-WASH. 
 
 goat α-mouse IgG H&L (conjugated with Alexa Fluor 647, AB150115, 
concentration 2 mg/ml) ‒ goat polyclonal secondary antibody to mouse 
IgG, Abcam, United Kingdom 
 
The antibody was prepared in dilution 1:2000 with FACS-WASH. 
3.1.4 Oligonucleotide primers 
Table 8 shows oligonucleotide primes used in the O-core PCR experiments. 
Table 8: Oligonucleotide primers used in O-core PCR (Amor et al., 2000). 
Preglednica 8: Oligonukleotidni primerji uporabljeni pri PCR za določanje O-sredice (Amot in sod., 
2000). 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.5 Standards, ladders and reagents 
Thermo Scientific, USA  
 PageRulerPrestained Protein Ladder, 10 ‒ 180 kDa 
Thermo Scientific (Fermantas), USA 
 GeneRuler 50 bp DNA Ladder 
ThermoFischer Scientific, USA 
 standard λ DNA/HindIII (0.5 µg/ml, 50 µg) 
Fermentas, USA 
 GeneRuler 1 kb DNA Ladder (0.5 µg/ml, 50 µg) 
 10× FastDigest Green Buffer 
Thermo Scientific, USA  
 DreamTaq Green PCR Master Mix (2×, K1081) 
Thermo Scientific, USA 
 6× DNA Loading Dye 
Oligonucleotide primers Nucleotide sequence (5`‒3’) 
R1C3 GGGATGCGAACAGAATTAGT 
R1K15 TTCCTGGCAAGAGAGATAAG 
R2C4 GATCGACGCCGGAATTTTTT 
R2K9 AGCTCCATCATCAAGTGAGA 
R3C2 GGCCAAAACACTATCTCTCA 
R3K13 GTGCCTAGTTTATACTTGAA 
R4C4 TGCCATACTTTATTCATCA 
R4K14 TGGAATGATGTGGCGTTTAT 
K12-1 TTCGCCATTTCGTGCTACTT 
K12-2a TAATGATAATTGGAATGCTGC 
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3.1.6 Kits and plates 
BD Biosciences, USA 
 BD Cell Viability Kit 
 Columbia Agar plates (1% sheep blood) 
3.1.7 Chemicals 
BD, USA 
 Bacto Tryptone – pancreatic digest of casein  
 BD Difco Skim Milk (medium for freezing the samples at –80 °C) 
Carl Roth, Germany 
 BSA albumin fraction V (endotoxin-tested)  
 sodium chloride (NaCl)  
 Tris 
 Tris-hydrochlorid (Tris-HCl) 
 sodium dodecyl sulfate (SDS - ultra pure) 
 β-mercaptoethanol 
 citric acid 
 LB-Medium (Luria/Miller) 
Carlo Erba Reagents, France 
 30% ammonia solution  
 sodium chloride (0,9% saline solution) 
Fermentas, USA  
 enzyme proteinase K 
Fluka Chemie, Switzerland 
 periodic acid  
Formedium, England 
 LB Broth Miller 
 Agar 
Gatt-Koller, Austria 
 96% ethanol  
Hungrana, Hungary 
 96% ethanol  
Kemika, Croatia 
 glycerol (redestilled) 
Merck, Germany 
 indicator bromphenol blue  
 37% formaldehyde solution 
 tetramethyl ethylenediamine (TEMED) 
Kociper M. Lipopolysaccharide structure and complement system response to selected Escherichia coli strains. 
   M. Sc. Thesis (Du2). Ljubljana, University of Ljubljana, Biotechnical Faculty, Academic Study in Microbiology, 2018 
 
25 
Sigma-Aldrich, Germany 
 Dulbecco's phosphate buffered saline (without calcium chloride and 
magnesium chloride) 
 sodium azide (NaN3) 
 silver nitrate (AgNO3) 
 ethylenediaminetetraacetic acid (EDTA) 
 acetic acid  
 acrylamide/bis-acrylamide (30% solution electrophoresis reagent) 
 ammonium persulfate (APS) 
 boric acid 
 Trizma base 
Zorka Šabac, Srbia 
 sodium hydroxide (NaOH) 
3.1.8 Buffers and reagents 
 FACS-WASH 
The FACS-WASH solution was prepared as follows: 5 g BSA was added to 500 ml 
DPBS solution (1% BSA). Also 500 mg NaN3 (0.1% NaN3) were added to prevent 
any growth of microorganisms in the solution. In the case FACS-WASH was used to 
determine the viability of the cells, the FACS-WASH was prepared as follows: PBS 
with 0.01% TWEEN 20 and 1 mM EDTA buffer.  
 Formalin 
1% formalin was prepared with mixing 1.35 ml 37% formalin and filling up with 
distilled water to 50 ml.  
 Spor-Klenz  
Spor-Klenz (trademark of Steris Corporation, St. Louis, Missouri) solution, used as a 
control for killing and staining dead bacteria with propidium jodide, was prepared 
with mixing hydrogen peroxide, acetic acid and paracetic acid. In flow cytometry it 
was applied according to the application note of BD Biosciences (Alsharif et al., 
2001).  
 Lysis buffer (without SDS) 
For the preparation of lysis buffer 0.946 g Tris-HCl and 0.0292 g EDTA were 
dissolved in 100 ml distilled water. In the final solution, the concentration of Tris-
HCl was 60 mM and EDTA was 1 mM. pH value of the final solution was set to 6.8 
with 1 M NaOH. 
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 Lysis buffer with SDS 
For the preparation of lysis buffer with SDS 2 g SDS, 0.946 g Tris-HCl and 0.0292 g 
EDTA were dissolved in 100 ml distilled water. In the final solution, the 
concentration of SDS was 2%, Tris-HCl was 60 mM and EDTA was 1 mM. pH 
value of the final solution was set to 6.8 with 1 M NaOH. 
 1 M Tris-HCl (pH = 6.8) 
In 100 ml bottle 6.06 g of Tris was weighted. The bottle was filled up to 50 ml with 
dH2O. The solution was stirred on a magnetic stirrer. pH value was measured. 
Concentrated HCl was added to lower the pH value to 6.8.  
 1,5 M Tris-HCl (pH = 8.8) 
In 100 ml bottle 6.06 g of Tris was weighted. The bottle was filled up to 50 ml with 
dH2O. The solution was stirred on a magnetic stirrer. pH value was measured. 
Concentrated HCl was added to adjust the pH value to 8.8.  
 Fixation buffer 
Fixation buffer was prepared with mixing 160 ml ethanol and 20 ml acetic acid, and 
filling up to 400 ml with MiliQ water. In the final solution, the concentration of 
ethanol was 40% and acetic acid 5%. 
 Oxidation buffer 
Oxidation buffer was prepared with mixing 160 ml ethanol, 20 ml acetic acid and 
3.8 g periodic acid for the oxidation of LPS, and filling up to 300 ml with MiliQ 
water. In the final solution, the concentration of ethanol was 40%, acetic acid 5% and 
periodic acid 0.7%. 
 Staining buffer 
Firstly, 29.4% NH4OH ammonia solution was prepared with adding 0.2 ml MiliQ 
water in 9.8 ml 30% ammonia solution. Secondly, 2 g AgNO3 was added to 10 ml 
MiliQ water to get 20% solution AgNO3. In the next step, 4 ml 29.4% NH4OH 
ammonia solution was added to 56 ml 0.1 M NaOH. Furthermore, to this solution 10 
ml 20% AgNO3 was added in dribs and drabs to prevent precipitation. Finally, the 
solution was diluted with MiliQ water to 300 ml volume. 
 Developing buffer 
Citric acid was prepared with 1 g citric acid added to 10 ml MiliQ water. 400 µl 10% 
citric acid and 400 µl 37% formaldehyde solution was added to 400 ml MiliQ water. 
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 Stop buffer 
Stop buffer was prepared with adding 28 ml acetic acid and filling up to 400 ml with 
MiliQ water. In the final solution, the concentration of acetic acid was 7%. 
 Loading buffer 
2× loading sample buffer was prepared with mixing 3 g SDS, 3 ml β-
mercaptoethanol, 23 ml glycerol, 0.473 g Tris-HCl and 0.1 g bromphenol-blue and 
filling up to 50 ml with MiliQ water. In the final solution the concentration of SDS 
was 6%, β-mercaptoethanol 6%, glycerol 46%, Tris-HCl 60 mM with pH 8 (pH 
value was set with 1 M NaOH) and concentration of bromphenol-blue 0.1%. 
 Running buffer 
10× Tris-glycine SDS-PAGE electrophoretic buffer was prepared with mixing 
30.285 g Tris, 144.134 g glycine and 10 g SDS in 1 l MiliQ water. In the final 
solution, the concentration of Tris was 250 mM, glycine 1.92 M and SDS 1%. 10× 
stock electrophoretic buffer solution was diluted to 1× solution with dH2O, which 
was used for electrophoresis.  
 5× TBE buffer 
5× TBE buffer was prepared with 54 g of Tris, 27.5 g of boric acid and 20 ml of 
0.5 M EDTA (pH = 8.0) in 1000 ml dH2O. 5× TBE stock buffer was 10-times diluted 
with dH2O to prepare 0.5× TBE buffer that was used in agarose gel electrophoresis.  
3.1.9 Laboratory equipment 
 DensiCHEK Plus Instrument, bioMérieux, USA  
 MICROFLOW biological safety cabinet, Unity Lab Services, USA 
 Protective laminar vertical work-bench SMBC 183, Iskra PIO, Slovenia 
 FACSVerse Flow Cytometer, BD, USA 
 FACSCanto II Flow Cytometer, BD, USA 
 analytical laboratory balance, Mettler Toledo, Switzerland 
 vortex, Phoenix Instrument, Germany 
 mixer mini vortex, VWR, USA 
 vortex, Vibromix 104 EV, Tehtnica, Slovenia 
 vortex, IKA Genius 3, Sigma Aldrich, USA 
 incubator, Memmert, Germany 
 autoclave, Memmert, Germany 
 centrifuge, Hettich Zentrifugen MIKRO 200R, Germany 
 centrifuge, Hettich Zentrifugen ROTANTA 460R, Germany 
 centrifuge, Sigma 4K10, Germany 
 inoculation loops and needles, Copan, Italy 
 single use-examination gloves, Sempermed, Singapore  
 automatic pipettes 0.5–10 µl, Starlab, Germany  
 automatic pipettes 2–20 µl, Eppendorf Research, Germany 
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 automatic pipettes 2–20 µl, Starlab, Germany 
 automatic pipettes 20–200 µl, Eppendorf Research, Germany 
 automatic pipettes 100–1000 µl, Eppendorf Research, Germany 
 automatic pipettes 100–1000 µl, Starlab, Germany 
 automatic pipettes 500–5000 µl, Eppendorf Research, Germany 
 automatic pipettes, Eppendorf Research, Germany 
 automatic pipettes, Lotrič Metrology, Slovenia 
 15 ml high-clarity polypropylene conical tubes, Falcon, México 
 50 ml polypropylene conical tubes,  
 10 µl graduated tips, Starlab TipOne, Germany  
 2–200 µl tips, Greiner Bio-One, Austria 
 50–1000 µl tips, Eppendorf, Germany 
 100–5000 µl tips, Eppendorf, Germany 
 1,5 ml micro-centrifuge tubes for high g-force, VWR, USA 
 1,5 ml micro tubes, Sarstedt, Germany 
 2 ml micro tubes (DNA LoBind tube), Eppendorf, Germany 
 5 ml polystyrene round-bottom tubes, Falcon, Mexico 
 5 ml polystyrene round-bottom tubes, Sarstedt, Germany 
 15 ml polypropylene conical base tubes, TPP (Techno Plastic Products), 
Switzerland 
 1 ml serological pipet, Life Sciences (FALCON Corning Incorporated), 
USA 
 713 pH Meter, Metrohm, Switzerland 
 Innova 2300 Platform-shaker, New Brunswick Scientific, USA 
 IKA RCT standars safety control magnetic stirrer, China 
 Rotamix 550 MMH scale, Tehtnica, Slovenia 
 Exacta 310 EB scale, Tehtnica, Slovenia 
 ET 1111 scale, Tehtnica, Slovenia 
 Kenwood Induction Hub IH100, Tokio, Japan 
 Centrifuge 5424, Eppendorf, Germany 
 Centrifuge 5415 R, Eppendorf, Germany 
 water bath ministat 125, Huber, Germany 
 laboratory water bath, Memmert, Germany 
 Mini Incubator, Labnet, USA 
 vortex Vibromix 10, Tehtnica, Slovenia 
 ultra-low temperature freezer Heto Ultra Freeze, Sanyo vip series model 
MDF-U54V, Japan 
 personal gel reader transiluminator, VWR Scientific, USA 
 electrophoresis power supply, Consort E143, Belgium and Consort E835, 
Belgium 
 orbital shaker (The Belly Dancer), Stovall Life Science, USA 
 mini cell for 1-D vertical gel electrophoresis, Mini-PROTEAN Tetra 
System, Bio-rad, USA 
 safety cabinet Waldner Laboreinrichtungen, Variolab Mobilien W 90, 
Germany 
 transilluminator G BOX, Syngene, India 
 microwave, Gorenje, Slovenia  
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3.2 METHODS 
LPS profiling with SDS-PAGE and LPS O-core specific PCR analyses were 
performed at Chair of Molecular Genetics and Biology of Microorganisms, 
Department of Biology, Biotechnical Faculty, University of Ljubljana. Analyses of 
factor H binding in FACS and binding of specific monoclonal antibodies in FACS 
were performed at Divison of Hygiene and Medical Microbiology, Department of 
Hygiene, Microbiology and Public Health, Medical University of Innsbruck. Further 
complement activation analyses with specific monoclonal antibodies and cell 
viability assays were performed in Laboratory for Flow Cytometry, Institute of 
Microbiology and Immunology, Medical Faculty, University of Ljubljana.  
3.2.1 LPS profiling 
3.2.1.1 LPS extraction 
E. coli strains, frozen at ‒80 °C, were placed on the LB agar plates and incubated 
over night at 37 °C. Next day, obtained colonies of each strain were inoculated into 
5 ml of liquid LB medium and incubated again overnight at 37 °C with shaking (180 
rpm). On the third day, 3 ml of overnight bacterial overnight culture was transferred 
into two 2 ml micro tubes (in each 1.5 ml) and centrifuged at 13 000 rpm for 1 min. 
The supernatant was discarded and pelleted cells were washed three times with 1 ml 
0.9% NaCl (saline solution). Between the washing steps, the cells were first vortexed 
and then centrifuged each time at 13 000 for 1 min and pelleted cells re-suspended in 
1 ml of fresh saline solution. After first washing step, both 1 ml suspensions were put 
together into one 2 ml micro tube. 
 
After third washing and centrifugation step, the cells were re-suspended in 125 µl of 
lysis buffer with SDS and vortexed. Afterwards, the samples were incubated (boiled) 
at 100 °C for 5 min. Then the samples were centrifuged again at 13 000 rpm for 1 
min and supernatant was discarded. Lysed cells were re-suspended in 75 µl lysis 
buffer solution without SDS, then 5.2 µl of proteinase K was added and incubated at 
65 °C for 2 h in water bath. LPS extracts were stored at 4 °C until further analyses.  
 
Next day, before the SDS-PAGE electrophoresis, 50 μl of LPS extract and 50 μl of 
loading buffer with β-mercaptoethanol were mixed in 1.5 ml micro tube, vortexed 
and incubated for 5 min at 100 °C. After the incubation, 7 µl of each sample was 
analyzed with Tris-glicin SDS-PAGE electrophoresis at 120 V. 
3.2.1.2 SDS-PAGE gel preparation and electrophoresis of LPS products 
The gel-casting system was assembled and the liquid gel solution was loaded in the 
space between two glass plates of the assembled system. The mixture for the 
stacking (by the bulk volume ~2 ml) and separating gel (by the bulk volume ~4 ml) 
was prepared in a beaker as shown in Table 9. TEMED was always added as last 
chemical. 
 
 
 
Kociper M. Lipopolysaccharide structure and complement system response to selected Escherichia coli strains. 
   M. Sc. Thesis (Du2). Ljubljana, University of Ljubljana, Biotechnical Faculty, Academic Study in Microbiology, 2018 
 
30 
Table 9: Preparation of gels for Tris-glycine SDS-PAGE electrophoresis. 
Preglednica 9: Priprava gelov za Tris-glicin SDS-PAGE elektroforezo. 
3% stacking gel 10% separating gel 
1.380 ml dH2O 1.426 ml dH2O 
0.200 ml acryl/bis-acrylamide (30%) 1.334 ml acryl/bis-acrylamide (30%) 
0.250 ml 1 M Tris-HCl, pH 6.8 1.000 ml 1.5 M Tris-HCl, pH 8.8 
0.020 ml 10% SDS 0.040 ml 10% SDS 
0.150 ml 10% APS 0.200 ml 10% APS 
0.002 ml TEMED 0.004 ml TEMED 
 
The chemicals were thoroughly mixed. Firstly, the mixture for separating gel was 
carefully transferred with pipette into the space between two glass plates in the 
assembled system. Afterwards, on the surface of the separating gel, a thin layer of 
water was added on both sides of the gel in order to prevent the contact with the air. 
Then polymerization step followed 30−45 minutes. When the separating gel was 
polymerized, the water on the surface was removed with filter paper. A layer of 
stacking gel was added onto the separating gel and the comb inserted. Again, 
polymerization step followed 30−45 minutes for the stacking gel to polymerize and 
afterwards the comb was removed. 
 
After the gel was prepared, it was inserted into the Mini-PROTEAN Tetra 
Electrophoresis System (Figure 9) and 1× Tris-glycine SDS-PAGE electrophoretic 
running buffer was added. Into the gel wells 8 or 10 µl of each sample and 4 µl of 
protein standard were loaded. On each gel, there were also positive controls for 
rough (E. coli MC4100) and smooth (E. coli DL94) strains. As already mentioned, 
electrophoresis was run at 120 V for around 45‒60 min. After the electrophoresis, the 
gels were carefully removed from the glass plates and put into plastic container for 
silver staining. 
 
Figure 9: The cell for SDS-PAGE vertical gel electrophoresis (Mini-PROTEAN Tetra System, 
Bio-rad, USA) (Photo: Kociper M.). 
On the picture we can see a blue front, marking loading buffer with samples, travelling down 
the separating gel. 
Slika 9: Celica za vertikalno gelsko elektroforezo SDS-PAGE (Mini-PROTEAN Tetra System, Bio-
rad, ZDA) (Foto: Kociper M.). 
Na sliki vidimo modro fronto, ki označuje nanašalni pufer z vzorci, ki potuje navzdol po ločevalnem 
gelu. 
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3.2.1.3 Silver staining (Tsai and Frasch, 1982) 
The gels were incubated in plastic containers (disposable plastic) with agitation on 
orbital shaker during each step. The buffers were discarded after each incubation 
step. The gels were first incubated in fixation buffer overnight. Next day, the 
incubation in oxidation buffer for 5 min followed. After oxidation, gels were washed 
three times with MiliQ water for 5 min. Following washing, gels were incubated in 
staining buffer for 10 min and afterwards washed again three times for 5 min in 
MiliQ water. Afterwards, incubation in developing buffer followed until the gels 
were sufficiently developed (around 3‒5 min). Finally, the staining was stopped with 
short incubation in stop buffer. The gels were stored in MiliQ water.  
3.2.1.4 Visualization 
Eventhough the bands on the gels were already seen to the naked eye as dark lines, 
they were thoroughly visualized with the G:Box system in the visible light. The 
pictures of the gels were further processed in program GeneSnap (Syngene) with 
function SilvaSDS. 
3.2.2 Lysate/supernatant preparation  
One colony of bacterial strain was inoculated in 5 ml of liquid medium LB and 
incubated overnight with agitation (220 rotates per minute) at 37 °C. Next day 1 ml 
of overnight bacterial culture was transferred into the micro tube and centrifuged for 
1 min. Then the supernatant was removed (completely, also with the help of pipette). 
The cells were re-suspended in 200 µl sterile distilled water. Suspension was 
incubated at 100 °C for 10 min. Then the micro tubes were centrifuged in the micro 
centrifuge for 10 min. Finally, 150 µl of the supernatant was transferred into a fresh 
micro tube and stored until further usage at ‒80 °C. Lysates were further used in 
PCR analyses, but first, in order to test the lysates, ERIC-PCR was performed 
according to Fajs et al. (2013). 
3.2.3 LPS O-core specific PCR 
The LPS core oligosaccharide type of the commensal E. coli (fecal) strains was 
determined. PCR reaction was carried out in a 20 µl reaction mixture in a micro tube 
containing: 
 2 µl dH2O 
 0.5 µl of each 10 primers (altogether 5 µl of primers)  
 10 µl DreamTaq Green PCR Master Mix (2X) 
 3 µl of E. coli lysate 
First dH2O, primers and DreamTaq Green PCR Master Mix were added and finally 
E. coli lysate. dH2O was used as a negative control. The amplification was carried 
out in Perkin Elmer GeneAmp PCR System 9600 as shown in Table 10. After the 
amplification the agarose gel electrophoresis of PCR products followed. 3 µl of each 
PCR product (and 2 µl of λ DNA/HindIII and 1 kb DNA Ladder) was put into the 
wells on 0.8% agarose gel and run for 1 h at 120 V. Two different standards (λ 
DNA/HindIII and 1 kb DNA ladder) were used to assess the size of the PCR 
products. 
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Table 10: PCR program for determining the O-core type in E. coli. 
Preglednica 10: PCR program za določanje tipa O-sredice pri E. coli. 
Oligonucleotide primers PCR program Reference 
R1C3, R1K15 94 °C 1 min 1×   
R2C4, R2K9, 94 °C 20 sec   
 
R3C2, R3K13 50 °C 30 sec 35× (Amor et al., 2000) 
R4C4, R4K14,  72 °C 2 min 15 s   
 
K12-1, K12-2a 72 °C 2 min 1×   
3.2.4 Agarose gel electrophoresis 
Agarose gel electrophoresis was performed in 0.5× TBE buffer. For 1% gel, 0.3 g of 
agarose was mixed in 30 ml 0.5× TBE in an Erlenmeyer flask. When different 
percentages of the gels were needed, the values were calculated accordingly. 
Erlenmeyer flask with the agarose was heated in the microwave until the agarose was 
completely dissolved. 1.3 µl of ethidium bromide with concentration 10 mg/ml was 
added to the solution and the solution was cooled down to around 60 °C with cold 
running water. Then the solution was poured into a plastic holder with a comb for the 
wells. When solidified, the comb was removed and the gel was put into the buffer 
chamber with 0.5× TBE electrophoresis buffer. 2 µl or 3 µl of the PCR sample was 
put into the wells. To assess the size of the PCR-products DNA Ladder, as suggested 
by the manufacturer Fermentas was loaded on the gel. The electrophoresis was run at 
120 V. The products on the gels were visualized in the G:Box with UV light. 
3.2.5 Preparation of E. coli samples for complement factor H and particle C7 
binding 
One inoculation loop of bacteria was inoculated into 5 ml of LB medium in the 
conical tube and incubated during the night in incubator at 37 °C. Next day the 
suspension of bacteria was centrifuged at 4600 rpm for 10 min. The supernatant (LB 
medium) was discarded and the bacteria was resuspended in 5 ml Dulbecco's 
phosphate buffered saline (DPBS solution). 
 
After the resuspension, the optical density was measured with optical densitometer 
(standard DPBS was used for calibration). 2 ml of the bacterial suspension was 
transferred into the plastic cuvette and measured with densitometer DensiCHEK Plus 
Instrument. If necessary, the suspension was further diluted with DPBS and the 
optical density was measured again. We set the optical density of the bacterial 
suspensions to OD600 = 1.4 (that means 4.2 × 108 CFU/ml  ̶  McFarland standard  to 
adjust the turbidity of bacterial suspensions). If necessary, we further diluted the 
suspensions with DPBS and measured the optical density again. 
3.2.1 Binding of complement regulatory protein factor H to the bacterial cell 
surface  
For each factor H binding assay three different samples (blank, negative control and 
sample with bacterial suspension) were prepared in 1.5 ml micro tubes as follows: 
 micro tube A: blank ‒ unstained sample (25 µl of bacterial suspension 
and 25 µl of DPBS), 
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 micro tube B: negative control (25 µl of bacterial suspension, 25 µl of 
DPBS, 50 µl of 1st antibody ‒ polyclonal rabbit IgG antibody to 
human CFH with Lot-specific concentration diluted 1:50, 50 µl of 2nd 
antibody ‒ goat polyclonal secondary antibody to rabbit IgG with 
concentration 2 mg/ml diluted 1:500, but without NHS),  
 micro tube C: sample with 10% NHS (25 µl of bacterial suspension, 
20 µl of DPBS, 50 µl of 1st antibody ‒ polyclonal rabbit IgG antibody 
to human CFH with Lot-specific concentration diluted 1:50, 50 µl of 
2nd antibody ‒ goat polyclonal secondary antibody to rabbit IgG with 
concentration 2 mg/ml diluted 1:500 and 5 µl of NHS) 
Experiments with three different commensal strains and control strain E. coli NCTC 
9001 were performed simultaneously on the same day. The samples were handled in 
the biological safety cabinet. 
 
Prepared mixtures were vortexed and incubated in incubator for 1 h at 37 °C. After 
the incubation, the samples were washed with 1 ml FACS-WASH, vortexed and 
centrifuged for 5 min at 10 000 rpm. Then the supernatant was discarded with 
serological pipet connected to a vacuum pump. The 1st antibody ‒ polyclonal rabbit 
IgG antibody to human CFH with Lot-specific concentration was diluted 1:50 with 
FACS-WASH and added in volume of 50 µl in the solution B and C. After 
discarding the supernatant in micro tube A, the bacteria in micro tube A were fixed 
with 500 µl of 1% formalin. The samples in micro tubes B and C were further 
handled, vortexed and incubated again for 30 min at room temperature.  
 
After the incubation the samples were washed with 1 ml FACS-WASH (same 
procedure as previously described) and the 2nd antibody ‒ goat polyclonal secondary 
antibody to rabbit IgG with concentration 2 mg/ml was diluted 1:500 with FACS-
WASH and added in volume of 50 µl into micro tubes B and C. The samples were 
vortexed and incubated again for 30 min at room temperature aside from direct light. 
 
Afterwards the samples were washed one more time with 1 ml FACS-WASH and 
fixed with 500 µl 1% formalin. The samples were stored in the fridge until further 
analyses with flow cytometer.  
3.2.2 Binding of complement particle C7 to the bacterial cell surface 
For each diluted suspension of E. coli strain, three different solutions were prepared 
in 5 ml polystyrene round-bottom tubes (first bacterial suspension, DPBS and NHS 
was added, and the antibodies later) as follows: 
 micro tube A: blank ‒ unstained sample (25 µl of bacterial suspension 
and 25 µl of DPBS), 
 micro tube B: negative control (25 µl of bacterial suspension, 25 µl of 
DPBS, 50 µl of 1st antibody antibody ‒ allotype-specific monoclonal 
mouse IgG1 antibody against human C7 particle with concentration 
1 mg/ml diluted 1:50, 50 µl of 2nd antibody ‒ goat polyclonal 
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secondary antibody to mouse IgG with concentration 2 mg/ml diluted 
1:500, but without NHS),  
 micro tube C: sample with 10% NHS (25 µl of bacterial suspension, 
20 µl of DPBS, 50 µl of 1st antibody ‒ allotype-specific monoclonal 
mouse IgG1 antibody against human C7 particle with concentration 
1 mg/ml diluted 1:50, 50 µl of 2nd antibody ‒ goat polyclonal 
secondary antibody to mouse IgG with concentration 2 mg/ml diluted 
1:500 and 5 µl of NHS) and 50% NHS (25 µl of bacterial suspension, 
50 µl of 1st antibody ‒ allotype-specific monoclonal mouse IgG1 
antibody against human C7 particle with concentration 1 mg/ml 
diluted 1:50, 50 µl of 2nd antibody ‒ goat polyclonal secondary 
antibody to mouse IgG with concentration 2 mg/ml diluted 1:500 and 
25 µl of NHS) 
The samples were handled in the biological safety cabinet. Prepared mixtures were 
vortexed and incubated in incubator for 1 h at 37 °C. After the incubation, the 
samples were washed with 1 ml FACS-WASH, vortexed and centrifuged for 5 min at 
10 000 rpm. Then the supernatant was discarded. The 1st antibody ‒ allotype-specific 
monoclonal mouse IgG1 antibody against human C7 particle was diluted 1:50 with 
FACS-WASH and added in volume of 50 µl in the solution B and C. After 
discarding the supernatant in micro tube A, the bacteria in micro tube A was already 
fixed with 500 µl of 1% formalin. The samples in micro tubes B and C were further 
handled, vortexed and incubated again for 30 min at room temperature in the dark. 
After the incubation the samples were washed with 1 ml FACS-WASH (same 
procedure as previously described) and the 2nd antibody ‒ goat polyclonal secondary 
antibody to mouse IgG was diluted 1:500 with FACS-WASH and added in volume 
of 50 µl into micro tubes B and C. The samples were vortexed and incubated again 
for 30 min at room temperature in the dark. Afterwards the samples were washed one 
more time with 1 ml FACS-WASH and suspended in 500 µl volume of PBS with 
0.01% TWEEN 20 and 1 mM EDTA buffer. 
3.2.3 Bacterial viability assay 
The cells were also stained with BD Cell Viability Kit that contains two dyes: 
thiazole orange and propidium iodide. 5 µl of each dye solution was added to 500 µl 
volume of suspended cells in PBS with 0.01% TWEEN 20 and 1 mM EDTA buffer 
(samples prepared as described in chapter Binding of complement particle C7 to the 
bacterial cell surface), vortexed and incubated for at least for 5 min at room 
temperature in the dark. Afterwards, the samples were immediately analyzed with 
flow cytometer. 
3.2.4 Flow cytometry analysis (FACS)  
We performed immunofluorescence flow cytometry analyses with BD FACSVerse 
(Figure 10) and BD FACSCanto II (Figure 11) flow cytometer. For analysis of flow 
cytometry data program BD FACSuite was used with BD FACSVerse flow 
cytometer and BD FACSDiva with BD FACSCanto II flow cytometer. The data was 
further analyzed in FlowJo program. 
 
Kociper M. Lipopolysaccharide structure and complement system response to selected Escherichia coli strains. 
   M. Sc. Thesis (Du2). Ljubljana, University of Ljubljana, Biotechnical Faculty, Academic Study in Microbiology, 2018 
 
35 
 
Figure 10: BD FACSVerse™ Flow Cytometer with  3 lasers, 8 color analysis and 4-2-2 
configuration ‒ one octagon and two trigon arrays, Cat. No. 651155 (Divison of Hygiene and 
Medical Microbiology in Innsbruck) (Photo: Kociper M.). 
Slika 10: FACSVerse™ pretočni citometer s tremi laserji, 8 barvno analizo in 4-2-2 konfiguracijo ‒ 
razporeditev v obliki enega oktagona in dveh trigonov (Divizija za higieno in medicinsko 
mikrobiologijo v Innsbrucku) (Foto: Kociper M.). 
 
Figure 11: BD FACSCanto™ II Flow Cytometer with  3 lasers, 8 color analysis and 4-2-2 
configuration ‒ one octagon and two trigon arrays (Laboratory for Flow Cytometry in 
Ljubljana) (Photo: Kociper M.). 
Slika 11: FACSCanto™ II pretočni citometer s tremi laserji, 8 barvno analizo in 4-2-2 konfiguracijo – 
razporeditev v obliki enega oktagona in dveh trigonov (Laboratorij za pretočno citometrijo v 
Ljubljani) (Foto: Kociper M.). 
Primary antibodies were aimed to complement factor H and complement particle C7. 
Fluorochrome in blue wavelength Alexa Fluor 488 bright, green-fluorescent dye and 
fluorochrome Alexa Fluor 647 bright, far-red-fluorescent dye were used as detection 
markers, which were conjugated with the secondary antibodies. Thiazole orange and 
propidium jodide were used for viability staining. Alexa Fluor 488 has an excitation 
peak at 490 nm and emission peak at 525 nm (Thermo Fischer Scientific, Alexa 
Fluor 488 dye), whereas Alexa Fluor 647 absorbs light best at 650 nm and emits best 
at 665 nm (Thermo Fischer Scientific, Alexa Fluor 647 dye). Fluorochromes for 
viability staining have the following dye fluorescence spectra: thiazole orange has an 
absorption wavelength maxima at 509 nm and emission maxima at 525 nm, whereas 
propidium jodide has an absorption wavelength maxima at 480‒580 nm (also UV) 
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and emission maxima at 623 nm (Givan, 2001). Fluorochromes with corresponding 
configuration are gathered in Table 11.  
Table 11: Fluorochromes with corresponding configurations and position on photomultiplier 
tubes.  
Preglednica 11: Fluorokromi s pripadajočo konfiguracijo in pozicijo na fotopomnoževalki.  
 
The BD FACSCanto II and BD FACSVerse flow cytometers are comparable. They 
have 4-2-2 optical configuration of photomultiplier tubes (PMT) arranged in one 
octagon (blue laser at 488 nm) and two trigons (red and violet lasers at 633 nm and 
405 nm, respectively) arrays where laser-excited light and side-scattered light is 
detected. On Figure 12 we can see an octagon configuration with corresponding 
mirrors and photomultiplier tubes position. The analyses were performed without 
spectral compensation. All the differences between BD FACSVerse and BD 
FACSCanto II, as well as differences between these two analyses with flow 
cytometers we can see in Table 12. 
 
Figure 12: Octagon detector array (BD Biosciences, 2007).  
Slika 12: Oktagon detektor (BD Biosciences, 2007).   
Fluorochrome 
Excitation 
maxima 
Emission 
maxima 
Laser 
color 
Dichroic 
mirror 
Filter 
PMT position or 
channel 
Alexa Fluor 488 490 525 blue 520 LP 530/30 
FITC  
(octagon) 
Alexa Fluor 647 650 665 red 685 LP 660/20 
APC  
(trigon) 
Thiazole orange 509 525 blue 520 LP 530/30 
FITC  
(octagon) 
Propidium jodide 480‒580 623 blue 655 LP 670 LP 
PerCP-Cy5.5 
(octagon) 
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Table 12: The differences between BD FACSVerse and BD FACSCanto II flow cytometer 
analyses. 
Preglednica 12: Razlike med analizami z BD FACSVerse in BD FACSCanto II pretočnim 
citometrom. 
 
 
BD FACSVerse  
(Innsbruck) 
BD FACSCanto II  
(Ljubljana) 
Parameter measured regulatory factor H  complement particle C7 
Software BD FACSuite v1.0.6 BD FACSDiva v8.0.1 
488 nm blue laser 
(octagon) 
488 nm blue solid state laser  
(octagon) 
640 nm red laser  
(trigon) 
633 nm red HeNe laser  
(trigon) 
405 nm violet laser 
(trigon) 
405 nm violet solid state diode laser  
(trigon) 
FSC* 
Si-photodiode with built-in 
488/10 BP filter 
photodiode with 488/10 BP filter 
SSC* PMT with 488/10 BP PMT with 488/10 BP 
Viability staining NO YES 
Threshold in analysis 200 on FSC 200 on SSC 
Serum pool only a few different donors fifty-five different donors 
Age of the serum pool couple of months old prepared in 2014 
Quantity of the serum  
5 µl in 50 µl reaction 
mixture 
5 µl and 25 µl in 50 µl reaction mixture, 
respectively 
Repetitions of the 
analysis 
3‒6 
one repetition with 5 µl and one with 25 
µl of NHS 
*(BD Biosciences, 2009; BD Biosciences 2012) 
3.2.5 Statistical analysis  
The data was analyzed in BD FACSuite v1.0.6 and BD FACSDiva v8.0.1, 
respectively. Further statistical analyses were performed in FlowJo, LLC v10.4.2, 
where median fluorescence intensities for complement factor H and particle C7 
binding were determined. 
 
The results were also statistically processed with Fischer’s exact test to see if there 
are any statistically relevant connections between activation of the complement 
system and appropriate virulence factors. Fischer’s exact test is accessible on the 
World Wide Web: http://www.langsrud.com/fisher.htm (Langsrud, 2018). 
Statistically relevant data were determined as data with T-tail p-value lower than 
0.05.  
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4 RESULTS  
4.1 LPS PROFILING (SDS-PAGE AND SILVER STAINING) 
LPS profiles of selected 14 commensal E. coli strains and strains E. coli MG1655, 
UPEC J96 and DH5α as revealed by SDS-PAGE and silver staining are shown on  
Figure 13. As seen from  
Figure 13, commensal strain E. coli BJ33, laboratory strain E. coli MG1655 and E. 
coli DH5α exhibit rough LPS profiles. All other commensal E. coli strains and the 
UPEC J96 strain exhibit smooth LPS profiles. However the smooth strains exhibit 
different LPS profiles according to: 
- the length of the LPS chains (position of the particular band),  
- the quantity of the certain LPS chain at the same length (thickness of the 
particular band) and  
- the number of different O-chains in the corresponding LPS (number of the 
bands). 
 
Evaluated by the naked eye, some of the strains exhibit similar LPS profiles, for 
example BJ16 and BJ23, BJ27 and BJ30, BJ93 and BJ97, respectively. 
On the photograph of gel D we can see the difference between rough E. coli BJ33 
and control for semi-rough profile of E. coli Nissle 1917. The significant difference 
is seen ‒ semi-rough profile is clearly much higher, because it has one O-chain in the 
LPS. 
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Figure 13: Silver-stained LPS profiles of E. coli strains on gels A, B, C and D, analyzed with 
SDS-PAGE electrophoresis.  
As a control for rough and smooth LPS profiles, strains E. coli MC4100 and E. coli DL94 were 
used, respectively (right on the pictures). Loading buffer was used as a zero standard.  
PageRuler Prestained Protein Ladder ranging from 10 to 180 kDa was used as an orientation 
standard for the length of O-chains in the LPS profile (left on the pictures). On the photograph 
of gel D we can see LPS profile of rough E. coli BJ33 and LPS profile of control for semi-rough 
strain of E. coli Nissle 1917.  
Slika 13: LPS profili sevov E. coli na gelih A, B, C in D, dobljeni s SDS-PAGE elektroforezo in 
barvanjem s srebrom.  
Kot kontrolo za gladki in hrapavi LPS profil smo uporabili seva E. coli MC4100 in E. coli DL94 
(desno na slikah). Nanašalni pufer je bil uporabljen kot ničelni standard. Uporabili smo tudi 
proteinsko lestvico PageRuler od 10 do 180 kDa kot orientacijski standard za dolžino O-verig v LPS 
profilu (levo na slikah). Na fotografiji D lahko vidimo LPS profil hrapavega seva E. coli BJ33 in LPS 
profil kontrole za semi-hrapavi sev E. coli Nissle 1917.  
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4.2 O-CORE SPECIFIC PCR 
PCR specific for five different O-cores of E. coli strains was performed and the 
products were visualized with agarose gel electrophoresis. As seen on Figure 14, four 
different core types were present among the analysed strains, but most of the strains 
had R1-core. Only R4-core was not found among these tested strains.  
 
Figure 14: Agarose gel electrophoresis (0.8% agarose gel) of O-core specific PCR products.  
We can see four different PCR products, which differ in size. 
1 – standard λ DNA/HindIII; 2 – dH2O; 3 – DL94; 4 – MC4100; 5 – J96; 6 – DH5α; 7 – 
MG1655; 8 – BJ97; 9 – BJ95; 10 – BJ93; 11 – BJ69; 12 – BJ67; 13 – BJ51; 14 – standard 1 kb 
DNA ladder;  15 – BJ34; 16 – BJ33; 17 – BJ30; 18 – BJ27; 19 – BJ23; 20 – BJ17; 21 – BJ16; 22 – 
BJ14; 23 – standard 1 kb DNA ladder 
Slika 14: Agarozna gelska elektroforeza (0,8 % agarozni gel) produktov, dobljenih s specifičnim PCR 
za O-sredico.  
Vidimo lahko štiri različne PCR produkte, ki se razlikujejo po velikosti.  
1 – standard λ DNA/HindIII; 2 – dH2O; 3 – DL94; 4 – MC4100; 5 – J96; 6 – DH5α; 7 – MG1655; 8 – 
BJ97; 9 – BJ95; 10 – BJ93; 11 – BJ69; 12 – BJ67; 13 – BJ51; 14 – standard 1 kb DNA ladder;  15 – 
BJ34; 16 – BJ33; 17 – BJ30; 18 – BJ27; 19 – BJ23; 20 – BJ17; 21 – BJ16; 22 – BJ14; 23 – standard 1 
kb DNA ladder 
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4.3 ESTABLISHMENT OF THE METHOD FOR COMPLEMENT FACTOR H 
AND COMPLEMENT PARTICLE C7 BINDING ASSAYS 
(IMMUNOFLUORESCENCE/BD FACSVerse) 
The methods (adapted from Kunert et al., 2007) were established with experiments 
on E. coli strain NCTC 9001 that is an uropathogenic strain, part of the National 
Collection of Type Cultures (provided by prof. dr. Reinhard Würzner). After several 
experiments, the data shows that the strain is positive for factor H and complement 
particle C7 binding as shown on Figure 15 and Figure 16. The data is gathered in 
Table 13, where the median and mean fluorescence intensities are listed (calculated 
with FlowJo). Therefore, the strain was used as positive control in flow cytometry 
analyses with BD FACSVerse.  
  
Figure 15: E. coli NCTC 9001 (single experiment), which is positive for factor H binding (BD 
FACSuite; grey ‒ negative control without NHS, red ‒ sample with NHS).  
On the left pictogram, all events are presented, on the right histogram only P1 events are 
presented, which are further gated with P2. 
Slika 15: E. coli NCTC 9001 (posamezen eksperiment), ki je pozitiven na vezavo faktorja H (BD 
FACSVerse; siva ‒ negativna kontrola brez NHS, rdeča ‒ vzorec z NHS).  
Na levem piktogramu vidimo vse dogodke, na desnem pa dogodke P1, ki so nadalje označeni s P2. 
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Figure 16: E. coli NCTC 9001 (single experiment), which is positive for C7 binding (BD 
FACSuite; grey ‒ negative control without NHS, red ‒ sample with NHS). 
On the left pictogram, all events are presented, on the right histogram only P1 events are 
presented, which are further gated with P2. 
Slika 16: E. coli NCTC 9001 (posamezen eksperiment), ki je pozitiven na vezavo C7 (BD 
FACSVerse; siva ‒ negativna kontrola brez NHS, rdeča ‒ vzorec z NHS).  
Na levem piktogramu vidimo vse dogodke, na desnem pa dogodke P1, ki so nadalje označeni s P2. 
 
Table 13: E. coli NCTC 9001 control strain statistics (BD FACSVerse). 
Preglednica 13: Statistika za kontrolni sev E. coli NCTC 9001 (BD FACSVerse). 
E. coli NCTC 
9001 
Number of 
relevant 
repetitions 
Median 
fluorescence 
intensity  
Average 
fluorescence 
intensity 
Factor H 
binding 
25 204.2 993.0 
Particle C7 
binding 
7 560.5 604.9 
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4.4 COMPLEMENT FACTOR H BINDING ASSAY 
(IMMUNOFLUORESCENCE/BD FACSVerse) 
All studied strains were tested for the factor H binding. The analyses were performed 
with 5 µl NHS in 50 µl reaction mixture. Cells were first gated on FSC/SSC analysis 
plot (P1) and secondly, the signal was gated on factor H binding/count plot (P2), as 
shown on Figure 17. Fluorescence intensity of Alexa Fluor 488 fluorochrome bound 
on the secondary antibody was the criterion for factor H binding. As an example, the 
results of flow cytometry analysis for E. coli strain BJ93 that was positive for 
complement factor H binding are depicted on Figure 17.  
 
Figure 17: E. coli  strain BJ93 (single experiment), which is positive for factor H binding (BD 
FACSuite; grey ‒ negative control without NHS, red ‒ sample with NHS). 
Slika 17: Sev E. coli BJ93 (posamezen eksperiment), ki je pozitiven na vezavo faktorja H (BD 
FACSuite; siva ‒ negativna kontrola brez NHS, rdeča ‒ vzorec z NHS). 
Positive parent cells (80.3%) were determined with P2 gate as seen on Figure 17. 
The experiments were repeated 3‒6 times, because sometimes the results were 
ambiguous (high fluorescence of negative control). Median fluorescence intensity of 
the fluorochrome was calculated in program FlowJo. Based on all repetitions, a 
quantitative scale was determined. Results of all E. coli strains regarding factor H 
binding are gathered in Table 14 and evaluated on a four-grade quantitative scale 0‒
3.  
Table 14: Results of factor H binding assays (statistical data of several repetitions). 
Preglednica 14: Rezultati eksperimentov vezave faktorja H (statistični podatki več ponovitev).  
Strain of  
E. coli 
BJ14 BJ16 BJ17 BJ23 BJ27 BJ30 BJ33 BJ34 BJ51 BJ67 BJ69 BJ93 BJ95 BJ97 
Factor H 
binding 
1 2 2 0 0 0 2 0 0 0 0 2 0 0 
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4.5 SPECIFIC MONOCLONAL ANTIBODIES TO COMPLEMENT PARTICLE 
C7 AND VIABILITY ASSAY (IMMUNOFLUORESCENCE/BD 
FACSCanto II) 
All studied strains were tested for the particle C7 binding. The analyses were 
performed with 5 µl NHS or 25 µl NHS in 50 µl reaction mixture, respectively. Cells 
were gated on two different diagrams (Figure 18): one region in the FSC/SSC 
analysis plot (P1) and another region in the TO/SSC plot (P2). Fluorescence intensity 
of Alexa Fluor 647 fluorochrome bound on the secondary antibody was the criterion 
for particle C7 binding. Cells were also stained with thiazole orange (TO) that stains 
live and dead cells, and propidium jodide (PI) that stains only dead cells. As an 
example, the results of flow cytometry analysis for E. coli strain BJ14 that was 
positive for particle C7 binding are depicted on Figure 18.  
 
 
Figure 18: FSC/SSC and TO/SSC point analysis plot for E. coli strain BJ14 (single experiment; 
25 µL NHS; BD FACSDiva).   
Green color (P2) depicts viable cells separated from other impurities and debris, which are 
depicted in black (all events) and red color (P1 events).  
Slika 18:  FSC/SSC and TO/SSC točkovni diagram za sev E. coli BJ14 (posamezen eksperiment; 25 
µL NHS; BD FACSDiva).  
Zelena barva (P2) prikazuje žive celice, ki so ločene od nečistoč in drobirja, prikazanih v črni (vsi 
dogodki) in rdeči barvi (dogodki P1). 
Cells in the region P2 were further analyzed on three different diagrams: 
- PI/count plot, 
- particle C7 binding (α-Ab conjugated with Alexa Fluor 647)/count plot and 
- particle C7 binding (α-Ab conjugated with Alexa Fluor 647)/PI plot. 
 
Median brightness intensity of the fluorochrome was determined on the C7 
binding/count diagrams, which indirectly show binding of complement particle C7 
(the criterion for complement activation). Higher median brightness intensity means 
better activation of the complement system. 
 
PI and C7 binding median brightness intensities obtained from the analyses on 
PI/count and C7 binding/count diagrams for E. coli strain BJ14 (with 25 µL NHS) 
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are depicted on Figure 19. On Figure 19 (left) we can see the histogram moved a bit 
right when sample with serum was used. On Figure 19 (right) we can see a strong 
shift of the diagram to the right; the fluorescence for C7 was clearly much higher in 
the sample with NHS. 
 
 
Figure 19: PI/count and particle C7 binding/count histogram analysis plot for E. coli strain 
BJ14 (single experiment; 25 µL NHS; BD FACSDiva).   
Blue color depicts negative control without NHS and green color sample with NHS. 
Slika 19: PI/število in vezava C7/število histogram za sev E. coli BJ14 (posamezen eksperiment; 25 
µL NHS; BD FACSDiva).  
Modra barva označuje negativno kontrolo brez NHS in zelena vzorec z NHS. 
 
C7 binding/PI point diagrams are represented on Figure 20. On the left (blue 
pictogram) is negative control, where the borders for the four quadrants were 
determined. As we can see on the right (green pictogram) the cells moved from 
quadrant 3 to quadrant 2 and 4, therefore there is a higher intensity of C7 binding 
(higher activation of the complement system) and higher fluorescence of PI (small 
quantity of the cells are presumably dead). Thus, usually a “comet” was formed on 
the pictogram. 
 
 
Figure 20: Particle C7 binding/PI analysis plots for E. coli strain BJ14 (single experiment; 25 µL 
NHS; BD FACSDiva; blue ‒ negative control without NHS, green ‒ sample with NHS). 
Slika 20: Vezava odlomka C7/PI točkovni diagram za sev E. coli BJ14 (posamezen eksperiment; 25 
µL NHS; BD FACSDiva; modra ‒ negativna kontrola brez NHS, zelena ‒ vzorec z NHS). 
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On Figure 21, the analysis plots of rough strain E. coli BJ33 with 5 µl NHS and 25 µl 
NHS are depicted. As we can see, there was a lower quantity of cells in the gate P2 
on TO/SSC diagram. This is not the case, if we used 25 µl of NHS, as shown on 
Figure 22. Strong immunofluorescence to C7 was detected for the cells in the 
“comet“ that were gated in the field P2. The cells in the “comet” were probably 
stacked together or lysed. 
 
 
Figure 21: TO/SSC point analysis plot of rough E. coli BJ33 exposed to 5 µl of NHS (single 
experiment; BD FACSDiva; left ‒ negative control without NHS, right ‒ sample with NHS).   
Slika 21: TO/SSC točkovni diagram za hrapavi sev E. coli BJ33, izpostavljen 5 µl NHS (posamezen 
eksperiment; BD FACSDiva; levo ‒ negativna kontrola brez NHS, desno ‒ vzorec z NHS).   
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Figure 22: TO/SSC point analysis plot of rough E. coli BJ33 exposed to 25 µl of NHS (single 
experiment; BD FACSDiva; left ‒ negative control without NHS, right ‒ sample with NHS).   
Slika 22: TO/SSC točkovni diagram za hrapavi E. coli BJ33, izpostavljene 25 µl NHS (posamezen 
eksperiment; BD FACSDiva; levo ‒ negativna kontrola brez NHS, desno ‒ vzorec z NHS).   
 
Table 15: Results of particle C7 binding assays (statistical data of several repetitions). 
Preglednica 15: Rezultati eksperimentov vezave odlomka C7 (statistični podatki več ponovitev). 
Strain of 
E. coli 
BJ14 BJ16 BJ17 BJ23 BJ27 BJ30 BJ33 BJ34 BJ51 BJ67 BJ69 BJ93 BJ95 BJ97 
Factor H 
binding ‒ 
5 µl NHS 
2 3 0 0 0 2 0 2 0 0 1 0 0 0 
Factor H 
binding ‒ 
25 µl NHS 
3 3 0 1 0 1 2 1 0 1 2 1 1 1 
4.6 STATISTICAL ANALYSIS 
4.6.1 FlowJo analysis 
Histogram of complement particle C7 and regulatory factor H binding intensity 
according to a certain E. coli strain is represented on Figure 23. The data was 
analyzed in program FlowJo, LLC (version 10.4.2). Binding intensities of factor H 
and particle C7 were determined as median brightness intensities of the 
fluorochromes Alexa Fluor 488 and Alexa Fluor 647 bound to corresponding 
secondary antibodes. 5 µl (light blue lines and red lines) and 25 µl (dark blue lines) 
of NHS was used in a 50 µl reaction mixture, respectively. Typical commensal strain 
E. coli SE15 was a negative control, two uropathogenic strains E. coli UPEC J96 and 
E. coli 536 were positive controls. Also two different uroseptic strains E. coli HS24 
and E. coli HS39 were tested. There is a high particle C7 median brightness intensity 
for all the rough strains analyzed (E. coli BJ33, MG1655 and DH5α), which we 
analyzed without the gate on TO/SSC diagram because the borders on the diagram 
could not be determined. 
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Figure 23: Regulatory factor H and complement particle C7 binding intensity according to a certain E. coli strain (statistical data of several repetitions).  
Factor H binding analyses were performed with BD FACSVerse (red ‒ with 5 µl NHS) and particle C7 binding analyses with BD FACSCanto II (light 
blue ‒ with 5 µl NHS, dark blue ‒  with 25 µl NHS). *536/NCTC 9001 – E. coli strain 536 tested only for particle C7 binding and strain NCTC 9001 only 
for factor H binding 
Slika 23: Intenziteta vezave regulatornega faktorja H in odlomka komplementa C7 glede na posamezni sev E. coli (statistični podatki več ponovitev).  
Analize vezave faktorja H so bile izvedene z BD FACSVerse (rdeča ‒ z 5 µl NHS) in analize za vezavo odlomka C7 z BD FACSCanto II (svetlo modra ‒ 5 µl 
NHS, temno modra ‒ 25 µl NHS). *536/NCTC 9001 – E. coli sev 536 testiran samo za vezavo odlomka C7 in sev NCTC 9001 samo za vezavo faktorja H
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4.6.2 Fischer’s exact test 
The correlation between activation of the complement system and virulence associated 
genes was examined with Fischer’s exact test. The ability of complement activation of 
each strain was determined based on the results obtained in the binding of particle C7 
assays and is presented in Table 16. None of the statistical correlations were determined, 
where the 2-tail P value was below 0.05 (Table 17). 
Table 16: Complement activation ability of the analysed commensal E. coli strains (several repetitions). 
Preglednica 16: Sposobnost aktivacije komplementa pri preučevanih komenzalnih sevih E. coli (več 
ponovitev). 
Strain of  
E. coli 
BJ14 BJ16 BJ17 BJ23 BJ27 BJ30 BJ33 BJ34 BJ51 BJ67 BJ69 BJ93 BJ95 BJ97 
Complement 
activation 
+ + - - + + + + - - + - - - 
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Table 17: Virulence associated genes and corresponding statistical p-values determined with Fischer’s 
test. 
Preglednica 17: Z virulenco povezani geni in pripadajoče statistične p-vrednosti, določene s Fischerjevim 
testom. 
 Complement activation 
 Positive Negative p- 
Virulence factor n = 7 n =7 value 
papGII 0 (7) 2 (5) 0,462 
papGIII 2 (5) 0 (7) 0,462 
afa/dra 0 (7) 0 (7) 1,000 
sfaDE 4 (3) 4 (3) 1,000 
iha 2 (5) 0 (7) 0,462 
fimH 6 (1) 6 (1) 1,000 
ibeA 1 (6) 4 (3) 0,266 
fyuA 5 (2) 7 (0) 0,462 
hbp 0 (7) 4 (3) 0,070 
ireA 2 (5) 3 (4) 1,000 
iucD 2 (5) 6 (1) 0,103 
iroN 6 (1) 7 (0) 1,000 
hlyA 3 (4) 0 (7) 0,192 
usp 5 (2) 6 (1) 1,000 
clbAQ 4 (3) 4 (3) 1,000 
picU 0 (7) 0 (7) 1,000 
kpsMT 5 (2) 6 (1) 1,000 
ompT 6 (1) 6 (1) 1,000 
APEC-ompT 2 (5) 5 (2) 0,286 
tcpC 4 (3) 0 (7) 0,070 
iss 1 (6) 3 (4) 0,559 
neuB 5 (2) 5 (2) 1,000 
traJ 2 (5) 6 (1) 0,103 
traT 2 (5) 6 (1) 0,103 
microcin M 2 (5) 1 (6) 1,000 
microcin V 2 (5) 6 (1) 0,103 
colicin B 0 (7) 4 (3) 0,070 
colicin M 0 (7) 4 (3) 0,070 
colicin E1 0 (7) 0 (7) 1,000 
colicin E7 1 (6) 2 (5) 1,000 
colicin la 1 (6) 3 (4) 0,559 
colicin ib 1 (6) 0 (7) 1,000 
colicin K 2 (5) 1 (6) 1,000 
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5 DISCUSSION 
The focus in this master thesis was on innate immune system, in particular complement 
system. We tested virulence potential of 14 selected E. coli fecal strains. For these strains 
different virulence associated genes that code for appertaining virulence factors had been 
determined as shown in Table 4. E. coli isolates with different set and number of virulence 
factors have been chosen for this thesis. All the previously obtained relevant data of analyzed 
E. coli strains is gathered in Table 18. It is known that LPS influences the innate immune 
response. This is why, we determined the structure of the E. coli membrane (LPS profile, 
number of different O-chains and the type of the outer part of O-core region). The criterion 
for complement response was binding of complement regulatory protein factor H and 
complement particle C7. Particle C7 is the key factor when the insertion of the membrane 
attack complex (MAC) into membrane starts. It is a part of lytic complex that causes lysis of 
the cells. Thus, binding of complement particle C7 was a measurement for complement 
activation. On the other hand, regulatory protein factor H can prevent the complement 
activation and represent the bacteria as one of the host’s cells. Therefore, bacteria can evade 
the complement response.  
 
Complement factor H and complement particle C7 binding was determined with flow 
cytometry. The signal was detected as median fluorescence intensity of the corresponding 
fluorochrome. In the flow cytometry analyses always indirect immunofluorescence with two 
different antibodies was applied. Primary antibody was aimed either to complement factor H 
or complement particle C7 bound on E. coli strain. Secondary antibody that was a detection 
antibody, was bound to primary and marked with fluorochrome. All the results of anti-factor 
H and anti-C7 antibody binding were characterized on a four-grade quantitative scale 
according to increasing intensity of the median fluorochrome brightness from 0 to 3. It should 
be taken into consideration that factor H binding was performed on BD FACSVerse and 
complement particle C7 binding on BD FACSCanto II, but the cytometers are comparable. 
The correlations between factor H and particle C7 binding are comparable under these 
conditions, as shown in Table 12. LPS profiling revealed E. coli BJ33 and two laboratory 
strains E. coli MG1655 and DH5α exhibit rough LPS profiles, all the other strains exhibit 
smooth LPS profiles, differentiated according to the length of the LPS chains, the quantity of 
the certain LPS chain at the same length and the number of different O-chains in the 
corresponding LPS. 
 
As we can see from the diagrams on Figure 20 (E. coli BJ14), bacterial strains are almost 
completely resistant to complement lysis (only a small percentage of cells are presumably 
dead). According to the literature smooth strains are serum-resistant and rough strains are 
serum-sensitive (Johnson, 1991). The cells of rough strains E. coli BJ33 (Figure 21 and 
Figure 22), MG1655 and DH5α were probably lysed because of the complement attack (other 
possible reason would be that some factor in the serum prevents the stain TO to enter the 
rough E. coli cells). All three strains exhibited the same TO/SSC pictograms with high 
immunofluorescence on C7 binding/count diagrams, which were completely different 
compared to the diagrams of all other smooth strains. The results coincide with LPS profile of 
those strains that were analyzed with SDS-PAGE gel electrophoresis, which confirmed rough 
LPS profiles. 
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Table 18: E. coli strains and their corresponding properties, regarding the structure of the membrane and interaction with complement system.*Scale for factor H 
median binding intensity: 0 (<50), 1 (50-100), 2 (100-200), 3 (>200). ** Scale for particle C7 median binding intensity: 0 (<50), 1 (50-100), 2 (100-150), 3 (>150). 
Preglednica 18: Sevi E. coli s pripadajočimi značilnostmi strukture membrane in interakcije s komplementnim sistemom. *Lestvica za mediano intenzitete vezave faktorja H: 
0 (<50), 1 (50-100), 2 (100-200), 3 (>200). ** Lestvica za mediano intenzitete vezave odlomka C7: 0 (<50), 1 (50-100), 2 (100-150), 3 (>150). 
E. coli strain 
Phylogenetic 
group 
Number of VAGs, 
including microcins and 
colicins 
LPS 
profile 
Approximate 
number of 
different O-
chains in LPS 
Type of  
O-core in 
LPS 
Factor H 
binding* 
(5 µl NHS)  
Particle C7 
binding** 
(5 µl NHS) 
Particle C7 
binding** 
(25 µl NHS) 
BJ14 B1 4 smooth 5 R3 1 2 3 
BJ16 A 2 smooth 16 K-12 2 3 3 
BJ17 A 4 smooth 11 R2 2 0 0 
BJ23 B2 21 smooth 15 R1 0 0 1 
BJ27 B2 14 smooth 10 R1 0 0 3 
BJ30 B2 13 smooth 10 R1 0 2 1 
BJ33 B2 15 rough 0 R1 2 0 2 
BJ34 B2 17 smooth 12 R1 0 2 1 
BJ51 B2 17 smooth 18 R1 0 0 0 
BJ67 B2 16 smooth 12 R1 0 0 1 
BJ69 B2 12 smooth 14 R1 0 1 2 
BJ93 B2 18 smooth 15 R1 2 0 1 
BJ95 B2 17 smooth 10 R1 0 0 1 
BJ97 B2 19 smooth 15 R1 0 0 1 
MG1655 / / rough 0 K-12 3 1 1 
DH5α / / rough 0 K-12 3 0 1 
UPEC J96 / / smooth 14 R1 2 3 3 
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According to the research of Johnson (1991), the degree of serum resistance is proportional 
to the amount of lipopolysaccharide the strain contains. In our case this this was not 
confirmed. BJ14 and BJ16 strains bind factor H and strongly activate the complement, but 
significant difference in LPS profile in the quantity and length of LPS O-chains of these 
two strains was observed.  
 
It is known that cells can withstand terminal MAC insertion. LPS can cause reduced or 
ineffective deposition of MAC or activation on the distal (non-sensitive) parts of the 
membrane, thus preventing lysis (Miajlovic and Smith, 2014; Johnson, 1991). 
 
According to the literature, ECOR phylogroups B2 and D harbour the majority of ExPEC 
strains (Boyd and Hartl, 1998; Picard et al., 1999; Branger et al., 2005), while commensal 
strains belong mostly to phylogenetic group A and B1 (Branger et al., 2005). In our case, 
the majority of our selected E. coli strains also belonged to the phylogenetic group B2. 
Only E. coli BJ14 belonged to group B1. E. coli BJ16 and BJ17 belonged to group A. . E. 
coli strains BJ14 and BJ16 bound factor H and activated the complement system. E. coli 
strain BJ17 bound factor H, but did not activate the complement.  
 
Strains used in this thesis that belonged to B2 phylogenetic group had only R1 core. E. coli 
strain BJ14 had R3 core. E. coli strains BJ16 and BJ17 had K-12 and R2 core, respectively. 
These results are in accordance with the literature  (Amor et al., 2000), as Amor et al. 
(2000) reported that i the phylogenetic group B1 primarily had R1 and R3 types,  group A 
all types of O-core and group B2 only R1 core (Amor et al., 2000).  
 
All employed strains activated the complement to some extent. Also typical commensal 
strain E. coli SE15, which served as a negative control slightly activated the complement. 
Analysis of the flow cytometry data is subjective to a certain degree. That is why, median 
brightness intensity below 50 was marked zero in the four-grade quantitative scale (not 
significant for complement activation). Commensal E. coli strains BJ14 and BJ16 activated 
the complement to the extent of uropathogenic UPEC J96 strain as shown in Figure 23. 
There was a significant difference in the intensity of the complement activation between 
the two uropathogenic and two uroseptic strains that were used in the study to reveal the 
effect of non-commensal strains.  
 
If we study thoroughly the results of factor H and particle C7 binding, we could categorize 
the used strains into 4 groups (Table 18): 
 strong factor H binding and weak (or non-existent) particle C7 binding  
(E. coli strains BJ17, BJ33, BJ93, MG1655 and DH5α marked in green) 
 strong particle C7 binding and weak (or non-existent) factor H binding  
(E. coli strains BJ14, BJ27, BJ30, BJ32, BJ34 and BJ69 marked in blue) 
 approximate the same intensities of factor H and particle C7 binding  
(E. coli strains BJ16 and UPEC J96 marked in gold) 
 weak (or non-existent) factor H and particle C7 binding  
(E. coli strains BJ23, BJ51, BJ67, BJ93 and BJ95 marked in grey) 
We anticipated that factor H binding would be a mean for evading the immune system by 
the strain, so if a strain binds factor H, it should not activate the complement system, and 
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vice versa (the first and second scenario in our research, marked in green and blue). 
However our result showed that the correlations are more complex. In the cases, where we 
had approximately the same intensities of factor H and particle C7 binding (marked in gold 
in Table 18), it looks as that factor H is in some way ineffective in preventing complement 
activation. Further, as only some strains are supposed to have the potential for 
extraintestinal infections, it was expected that some strains would not bind nor factor H nor 
particle C7. A strong factor H binding was especially seen for strains BJ17, BJ33 and 
BJ93, where C7 binding was almost non-existent. Taken together, among all the selected 
E. coli strains, the E. coli strains BJ17, BJ33 and BJ93 could be those that could evade the 
immune system with binding of specific complement regulatory protein H. On the other 
hand, all smooth BJ strains were very resistant to complement killing. Further experiments 
are required to profoundly determine the relations between regulatory factor H acquisition 
and particle C7 complement activation. It would also be interesting to find a different 
criterion for complement activation such as particle C9 binding and compare it to particle 
C7 binding. 
 
Several microorganisms have been identified to bind factor H or FHL1 in order to protect 
cell surfaces from alternative complement pathway activation (Rodríguez De Córdoba et 
al., 2004). The studies on Pseudomonas aeruginosa (P. aeruginosa) showed that binding 
of factor H and (also CFHL1 and CFHR1) seems to be a general feature of P. aeruginosa 
strains and is used for complement control and tissue invasion. Factor H binds to 
translational elongation factor Tuf on P. aeruginosa via two binding regions, i.e. SCRs 6-7 
and SCRs 19-20, and bounded maintains functionally active via cofactor activity (Kunert 
et al., 2007). Hallström et al. (2012) discovered the second complement regulator-binding 
protein of P. aeruginosa called Lpd. Lpd is a dihydrolipoamide dehydrogenase surface-
exposed protein and virulence factor that binds factor H, CFHL1, and CFHR1. Lpd protein 
is a virulence factor that aids in complement evasion as well as extracellular matrix 
degradation when bound to factor H, CFHL1, and CFHR1 (Hallström et al., 2012). Outer 
membrane protein Rck (resistance to complement-mediated killing) encoded on the 
virulence plasmid of Salmonella enterica serovars Typhimurium and Enteritidis binds 
factor H. The binding was associated with resistance to alternative pathway-mediated 
killing and reduced deposition of C3b, Bb, and MAC. FH bound to Rck also promoted C3b 
cleavage in the presence of factor I (Ho et al., 2010). Also for Haemophilus influenzae was 
shown to bind factor H and CFHL1. Furthermore, the high-affinity FH-binding strains 
were more resistant to serum-mediated killing that the low-affinity strains (Hallström et al., 
2008). 
 
The type E. coli strain NCTC 9001 was used as a control in complement factor H binding 
analyses. It was tested several times on different days along other fecal E. coli isolates and 
strongly confirms that E. coli can bind factor H. To our knowledge, there has not yet been 
proven that bacteria E. coli binds factor H. Also correlation between factor H binding and 
complement particle C7 binding has not yet been assessed. E. coli has an outer membrane 
protein OmpX that belongs to a family of highly conserved 17‒19 kDa proteins such as 
Rck in Salmonella for which it was proven that binds factor H (Heffernan et al., 1992; Ho 
et al., 2010). Therefore, complement factor H could bind to OmpX in E. coli. The same 
strain can bind factor H and also activate complement system (bind complement particle 
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C7) in high intensity, what was also proven with the strain E. coli NCTC 9001, where 
several repetitions were performed. That is not surprising as these two complement 
proteins bind to different receptors on the same bacteria.  
 
E. coli strains BJ14, BJ16 and BJ17 have the least virulence factors, if taken all-together in 
Table 18. Strains BJ14 and BJ16 strongly activate the complement system, meanwhile 
strain BJ17 not at all. Statistically relevant connections between virulence factors and the 
activation of the complement system were not found (Table 17). More strains should be 
tested to gain possible statistical connections.  
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6 CONCLUSIONS 
The purpose of this thesis was to study the factor H and particle C7 binding ability of 
healthy people's gut microbiota E. coli strains possessing known extraintestinal pathogenic 
E. coli virulence associated genes and to determine the lipopolysaccharide profile of the 
studied strains. Following conclusions were drawn: 
 
 Selected E. coli isolates had smooth LPS profile, except for the strains BJ33, 
MG1655 and DH5α that were rough. Lipopolysaccharide profile of the studied E. 
coli strains did not always correlate with the strength of the complement response. 
 
 Smooth strains of bacteria were very resistant to complement killing, even if they 
were detected by the complement (determined by binding particle C7), and rough 
strains were serum sensitive (presumably lysed by the complement). 
 
 Most of the studied E. coli isolates had the R1 type of the outer O-core region. 
 
 E. coli strains from the gut microbiota of healthy humans that possessed virulence 
associated genes were capable of triggering the host's immune system, in particular 
complement system (determined by binding particle C7), even to the intensity of 
activation of pathogenic strains.  
 
 To our knowledge, this is the first research revealing different complement factor H 
binding abilities of E. coli strains. 
 
 Some of the analysed E. coli strains could be able to avoid the immune system 
activation by binding regulatory factor H. 
 
Further data on a larger set of bacterial E. coli strains is required to profoundly determine 
the relations between regulatory factor H acquisition and particle C7 complement 
activation, and virulence potential of E. coli strains.  
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7 SUMMARY 
7.1 SUMMARY 
Escherichia coli (E. coli) is a Gram-negative motile facultative anaerobic coliform 
bacterium (Andalovic, 2002). It is part of the normal intestinal microbiota in humans and 
other mammals. Usually, it has a mutualistic relationship with its host, but some E. coli 
strains have acquired specific virulence factors and can cause a variety of infections. Those 
E. coli strains are known as extraintestinal pathogenic E. coli (ExPEC). Different 
virulence-associated genes (VAG) that code for specific virulence factors (VF) have been 
identified among those strains.  
 
In the study, we have investigated whether E. coli strains of the healthy human gut 
microbiota that have ExPEC VAGs are able to trigger complement system response that is 
one of the first lines of defense in the innate immunity. Different factors that influence 
complement system response have been investigated. In particular, we determined the 
structure of the E. coli membrane (LPS profile and type of the outer part of O-core region). 
The criterion for complement response was binding of complement particle C7, and we 
also tested binding of complement regulatory protein factor H as an evading mechanism of 
complement activation. 
 
Lipopolysaccharide (LPS) structure was determined by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and silver staining. LPS profiling 
revealed that E. coli BJ33 and two laboratory strains E. coli MG1655 and DH5α exhibit 
rough LPS profiles, all the other strains exhibited smooth LPS profiles, differentiated 
according to the length of the LPS chains, the quantity of the certain LPS chain at the same 
length and the number of different O-chains in the corresponding LPS (some strains 
exhibited similar smooth LPS profiles). Lipopolysaccharide profile of the studied E. coli 
strains did not necessarily correlate with the strength of the complement response. Smooth 
strains of bacteria were presumably very resistant to complement lysis when detected, 
while rough strains were complement sensitive. The type of the outer part of O-core in LPS 
was determined with specific primers employing polymerase chain reaction (O-core PCR). 
Most of the studied strains exhibited R1 type of outer O-core region, which is typical for 
B2 and D phylogenetic group that is associated with the majority of ExPEC strains. 
 
Furthermore, it was assessed, if the studied E. coli strains differ in their ability to activate 
complement system (bind complement particle C7) and bind specific complement 
regulatory protein factor H. Specific antibodies were bound to E. coli strains and the 
indirect immunofluorescence analysis was performed on the flow cytometer (BD 
FACSVerse™ and BD FACSCanto™ II). Viability staining was performed with thiazole 
orange and propidium jodide. E. coli strains of the gut microbiota of healthy humans were 
capable of triggering the complement activation, some strains even to the extent of 
uropathogenic strains. To our knowledge, this is the first research revealing different 
complement factor H binding abilities of E. coli strains. Some E. coli isolates also bind 
factor H, which could serve as an evading mechanism against complement activation.  
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7.2 POVZETEK 
Escherichia coli (E. coli) je po Gramu negativen gibljivi fakultativno anaerobni bacil 
(Andalovic, 2002). Bakterija E. coli je del normalne črevesne mikrobiote človeka in drugih 
sesalcev; nahaja se v mukozni plastni debelega črevesja kot najbolje zastopan fakultativni 
anaerob (Kaper in sod., 2004). S človekom je običajno v mutualističnem odnosu, saj nas 
ščiti pred patogenimi mikroorganizmi kot del črevesne bariere in za nas sintetizira vitamin 
K. Po drugi strani pa obstajajo tudi patogeni, virulentni sevi, ki povzročajo različne 
črevesne in zunajčrevesne okužbe. Bakterije E. coli lahko, glede na genetske in klinične 
kriterije, uvrstimo v skupine: 
- komenzalni sevi E. coli, 
- črevesni patogeni sevi E. coli (IPEC) in 
- zunajčrevesni patogeni sevi E. coli (ExPEC) (Russo in Johnson, 2000). 
 
Komenzalni sevi v zdravem gostitelju običajno ne povzročajo bolezni, saj jim manjkajo 
specifični virulentni dejavnki, ki so prisotni pri črevesnih in zunajčrevesnih sevih E. coli 
(Russo in Johnson, 2000).  
 
Virulentni dejavniki (VF) so proteini, ki jih kodirajo z virulenco povezani geni (VAG), ki 
se nahajajo in se prenašajo predvsem na otokih patogenosti (PAI); številne PAI so našli 
tudi pri sevih ExPEC (Schmidt in Hansel, 2004). Večina sevov ExPEC spada v 
filogenetsko skupino B2 (Boyd in Hartl, 1998; Branger in sod., 2005). Virulentni dejavniki 
sevov ExPEC spadajo v različne funkcionalne kategorije kot so adhezini, invazini, 
mehanizmi za pridobivanje železa, toksini in protektini (Kohler in Dobrindt, 2011; Starčič 
Erjavec in Žgur-Bertok, 2015). Adhezini in eksotoksini so najbolj pomembne značilnosti 
povezane z virulenco sevov E. coli (Mainil, 2013). Komenzalni sevi E. coli bi lahko 
delovali kot trojanski konj, saj s pridobitvijo z virulenco povezanih genov, pridobijo 
sposobnost patogeneze (Starčič Erjavec in Žgur-Bertok, 2015).  
 
Bakteriocini so toksični proteini, ki jih sintetizirajo določeni sevi bakterij in so aktivni proti 
sorodnim sevom. Nekateri sevi E. coli so tako sposobni sinteze bakteriocinov, imenovanih 
kolicini, ki so toksični za sorodne seve E. coli (Cascales in sod., 2007). Nekateri sevi E. 
coli pa so sposobni sinteze mikrocinov, bakteriocinov, ki so manjši od10 kDa (Kastin, 
2006). Pri E. coli s karakteristikami ExPEC so pogosteje prisotni geni, ki kodirajo sintezo 
kolicinov in mikrocinov (Micenková in sod., 2014). 
 
Človeški imunski sistem delimo na dva načina: i) na prirojeni (nespecifični) in pridobljeni 
(specifični) imunski sistem ter ii) na humuralni in celični imunski sistem. Humoralni 
imunski sistemje usmerjen proti bakterijskim in virusnim okužbam (učinkuje na bakterije 
in viruse, ki jih najde v telesnih tekočinah), celični imunski sistem pa uničuje celice 
okužene z virusi, parazite in tuja tkiva (Lehninger in sod., 2005). Humoralni prirojeni 
imunski sistem sestavljajo komplementni sistem, proteini akutne faze in različni citokini, 
medtem ko celični prirojeni imunski sistem sestavljajo sledeče celice: monociti in 
makrofagi, polimorfonuklearni granulociti, mastociti, dendritične celice in celice naravne 
ubijalke. 
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Komplementni sistem, ki je del prirojenega imunskega odziva, je sestavljen iz številnih 
proteinov, ki so bodisi v telesnih tekočinah ali na površni celic. Glavni vir 
komplementnega sistema so jetra. Komplementni sistem se aktivira v kaskadnem 
zaporedju na tri različne načine, zato poznamo tri različne poti aktivacije komplementnega 
sistema: klasična, alternativna in lektinska pot. Aktivacijo klasične poti komplementnega 
sistema povzročijo imunski kompleksi. Alternativno pot aktivirajo patogeni, ki vstopijo v 
organizem. Lektinska pot se aktivira, kadar pride do interakcije mananskih ostankov v 
ogljikohidratnih molekulah mikroorganizmov  s proteini, ki vežejo manozo. Vse poti 
komplementnega sistema se zaključijo z nastankom litičnega oz. terminalnega kompleksa 
(TCC), ki ga imenujemo tudi MAC ali odlomek C5b-9. Ta kompleks konstruira cilindrično 
poro s premerom 10 nm v membrani, ki povzroči izmenjavo elektrolitov in posledično lizo 
celice (Ihan in Kotnik, 2002; Schwaeble in sod., 2013). 
 
Regulatorji aktivacije komplementa (RCA) omogočajo, da ne pride do aktivacije na telesu 
lastnih celicah. Pretirana aktivacija komplementa lahko vodi v različne avtoimunske 
bolezni. Regulatorji komplementnega sistema, ki so med seboj strukturno podobni, so 
sledeči: komplementni receptor 1 (CR1), faktor H (FH), faktorju H-podoben protein (FHL-
1), C4-vezujoči protein (C4BP), faktor pospeševanja razgradnje (DAF) in membranski 
kofaktorski protein (MCP) (Lambris in sod., 2008).  
 
Mikrobi uporabljajo različne strategije, da se izognejo gostiteljevemu imunskemu sistemu: 
vezava molekul, ki posnemajo komplementne regulatorje, modulacija ali inhibicija 
komplementnih proteinov preko direktne interakcije in inaktivacija z encimsko razgradnjo. 
Te strategije so osredotočene na komplementni sistem, saj predstavlja center prirojene 
imunosti in prvo linijo obrambe proti patogenim mikroorganizmom (Lambris in sod., 
2008). V magistrski nalogi smo se osredotočili na komplementni regulatorni faktor H. 
 
Faktor H je plazemski glikoprotein, zgrajen iz ene polipeptidne verige z molekulsko maso 
155 kDa. Govorimo o regulatornem protein, ki regulira komplement v tekoči fazi kot na 
celičnih površinah (Rodríguez De Córdoba in sod., 2004). Veže se na odlomek C3b in s 
tem prepreči vezavo faktorja B in nastanek C3 konvertaze (C3bBb) po alternativni poti 
komplementa. Ima visoko afiniteto vezave na odlomek C3b na telesu lastnih celicah in 
nizko na bakterijskih celicah, kar pomeni, da na telesu tujih celicah pride do nadaljnje 
aktivacije komplementa. Faktor H je tudi kofaktor za faktor I, ki razgrajuje C3b v iC3b in 
na koncu v C3d, kar prepreči nastanek C3 konvertaze. Deluje pa tudi kot faktor, ki pospeši 
razgradnjo C3 konvertaze (Pouw et al., 2015). Regulatorni mehanizmi torej inhibirajo 
aktivacijo komplementnega sistema po alternativni poti. Bakterije, ki vežejo faktor H pa se 
lahko izognejo napadu komplementnega sistema. 
 
Faktor H je spada v družino proteinov CFH, kamor spadajo tudi drugi regulatorni proteini: 
CFH-podoben protein 1 (CFHL1) in CFH-sorodni proteini (CFHR1-5) (Józsi in Zipfel, 
2008). Številni mikroorganizmi in tumorske celice so sposobni vezati faktor H in CFHL1, 
z namenom, da zaščitijo celično površino pred aktivacijo komplementnega sistema 
(Rodríguez De Córdoba in sod., 2004). Vezava regulatorjev aktivacije komplementa 
(RCA) je značilna za bakterije, bila pa je tudi opisana pri virusih, glivah in parazitih 
(Lambris in sod., 2008). Nekateri izmed mikroorganizmov, ki lahko vežejo faktor H, so 
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Borrelia burgdorferi, Candida albicans, Echinococcus granulosus, Neisseria gonorrhoeae, 
Onhocerca volvulus, Streptococcus pneumoniae in Yersinia enterocolitica (Rodríguez De 
Córdoba in sod., 2004). 
 
Celična stena po Gramu negativnih bakterij je kompleksna večslojna struktura zgrajena iz 
citoplazemske membrane, periplazme s peptidoglikanom in zunanje membrane. Zunanja 
membrana predstavlja večino celične stene in je v glavnem zgrajena iz lipopolisaharida 
(LPS), najdemo pa tudi fosfolipide, transmembranske proteine, kot so porini in 
lipoproteine. Porini omogočajo večjo permeabilnost zunanje membrane v primerjavi s 
citoplazemsko membrano (Madigan in sod., 2009). LPS je močan aktivator imunskega 
sistema in nujen za preživetje po Gramu negativnih bakterij (Erridge in sod., 2002). V 
osnovi je zgrajen iz fosforiliranega diglukozaminskega ogrodja substituiranega z več 
acilnimi verigami in najmanj enim ostankom Kdo (Erridge in sod., 2002). LPS ima 
negativen naboj in omogoča integriteto in stabilnost zunanje membrane LPS (Reyes in 
sod., 2012). V LPS lahko ločimo tri različne regije: lipid A, središčni oligosaharid in O-
antigen (Caroff in sod., 2002).  
 
Lipid A predstavlja ogrodje LPS, zgrajeno iz dveh β-1,6-D-glukozaminov. Na disaharid, ki 
je bifosforiliran, so preko estrskih in amidnih vezi vezane maščobne kisline (acilni 
substituenti) (Zähringer in sod., 1999). Študije so pokazale, da ima difosforiliran E. coli-
podoben heksaaciliran lipid A, ki vsebuje dva D-glukozamina, povezana z β-1-6-vezjo,  
največjo endotoksično aktivnost; deviacije od te zgradbe zmanjšujejo aktivnost (Erridge in 
sod., 2002).  
 
Središčni oligosaharid je razdeljen iz bolj ohranjene notranje sredice in variabilnega 
zunanjega oligosaharida. V notranjem oligosaharidu najdemo tipični sladkor Kdo (Erridge 
in sod., 2002). Zunanji variabilen oligosaharid določa enega izmed petih različnih tipov 
oligosaharidne sredice, ki ga lahko določimo z metodo LPS tipiziranja s PCR: R1, R2, R3, 
R4 in K-12 (Amor in sod., 2000).    
 
O-antigen je zgrajen iz ponavljajočih se podenot, ki so prisotne samo pri gladkem tipu po 
Gramu negativnih bakterij. Vsaka podenota je zgrajena iz enega do osmih sladkorjev, v 
posameznem O-antigenu pa je lahko tudi do 50 podenot. O-antigen določa tudi serotip 
bakterije, saj je velika variabilnost pripeljala do unikatnih verig pri bakterijah. Poznamo tri 
različne tipe LPS glede na število O-antigenskih enot: gladki (S) z več O-antigenskimi 
verigami, semi-hrapavi (SR) z eno O-antigensko verigo in hrapavi (R) brez O-antigena 
(Caroff in sod., 2002; Caroff in Karibian, 2003).  
 
Pretočna citometrija je pomembna metoda za analizo fizikalnih in kemijskih karakteristik 
različnih delcev v majhnih količinah kot so celice, antigeni in protitelesa. Glavni deli 
pretočnega citometra so svetlobni vir, komora z optičnim sistemom leč, ogledal in filtrov, 
elektronika za transformacijo svetlobnih impulzov v električne in nadalje digitalne signale, 
ter računalniški sistem za analizo, koordinacijo in regulacijo celotnega sistema (Ihan in 
Kopitar, 2010). Pretočni citometer je torej zgrajen iz treh sistemov, ki imajo vsak svojo 
funkcijo: fluidika transportira delce v suspenziji k laserskemu žarku, optika, sestavljena iz 
 Kociper M. Lipopolysaccharide structure and complement system response to selected Escherichia coli strains. 
   M. Sc. Thesis (Du2). Ljubljana, University of Ljubljana, Biotechnical Faculty, Academic Study in Microbiology, 2018 
 
61 
laserjev, osvetljuje delce in usmerja signale k detektorjem, elektronika pa spremeni 
svetlobne signale v elektronske, ki jih procesira računalnik (BD Biosciences, 2000).  
 
Pretočni citometri uporabljajo različne kombinacije laserjev in fluorokromov. Laserji so vir 
svetlobe v obliki fotonov z določeno valovno dolžino in energijo. Fluorokromi so kemijske 
spojine, ki se aktivirajo pri določeni valovni dolžini (ekscitacija) in oddajajo svetlobo pri 
drugačni valovni dolžini (emisija). Za fluorokrome je značilne absorpcijski in emisijski 
interval z maksimumom pri določeni valovni dolžini. Razlika v orbitalnih energijah 
natančno določa valovno dolžino, ki jo fluorokromi lahko absorbirajo, zato izbira laserja v 
pretočnem citometru omejuje izbiro fluorokromov za označevanje celic. Svetlobo, ki se 
razprši na celici ali jo emitirajo različni fluorokromi na tej celici, zaznajo fotodetektorji. 
Sipano svetlobo merimo z dvema fotodetektorjema, kjer je eden postavljen v smeri 
svetlobnega vira (FSC), drugi pa pravokotno glede na sipano svetlobo (SSC). Svetloba, ki 
jo emitirajo fluorokromi, je različnih barv oz. valovne dolžine ter prehaja skozi sistem 
ogledal in filtrov do fotodetektorjev (Ihan in Kopitar, 2010; Givan, 2001). Sipana svetloba 
v smeri svetlobnega vira, ki jo zaznava detektor FSC nam pove informacije o površini oz. 
velikosti celice, svetloba pravokotno na smer svetlobnega vira, ki jo zaznava detektor SSC 
pa granuliranost ali notranjo kompleksnost celice (BD Biosciences, 2000). 
  
Poliakrilamidna gelska elektroforeza v prisotnosti natrijevega dodecilsulfata (SDS-PAGE) 
je posebna oblika gelske elektroforeze za določanje velikosti in kompozicije podenot 
proteinov. Pri tej metodi se proteini premikajo skozi zamreženi poliakrilamidni gel. 
Proteini se nahajajo v močnem negativno nabitem detergentu natrijevega dodecilsulfata, 
bolj znanem kot natrijev lavrilsulfat. Dodan je tudi reducirajoči agens β-merkaptoetanol, ki 
cepi S-S vezi med proteini. Ta tehnika torej omogoča analizo posameznih proteinov. Veliki 
proteini se premikajo počasneje v gelu, ki deluje kot molekularno sito, manjši pa hitreje. 
Rezultat je serija diskretnih proteinskih »trakov ali lis«, razporejenih glede na molekularno 
maso (Alberts in sod., 2008). Geli se na koncu oksidativno obarvajo z barvilom iz srebra, 
ki omogoča detekcijo že 10 ng proteina. Barvajo se lahko proteini ali ogljikovi hidrati, kar 
pomeni, da se glikoproteini v LPS tudi obarvajo (Tsai in Frasch, 1982). Število 
ponavljajočih verig v O-polisaharidni verigi v celični membrani mikroorganizmov je 
različno (od 1 do 50) zaradi nepopolne sinteze posameznih verig. Pri SDS-PAGE 
elektroforezi se lipid A veže na SDS in potuje skozi poliakrilamidni gel skupaj z O-
antigenom. Ker so verige različno dolge, je rezultat profil v obliki lestvice s traki ali lisami 
na gelu. Lise predstavljajo število ponavljajočih se enot v O-polisaharidu, razmiki med 
lisami pa velikost ponavljajočih se podenot (Goldman and Leive, 1980; Palva and Mäkelä, 
1980; Tsai and Frasch, 1982; Erridge et al., 2002). 
 
V magistrskem delu smo se osredotočili na bakterijske seve E. coli in komplementni 
sistem, ki je ključni sistem kompleksnega prirojenega imunskega odziva. Interdisciplinarno 
raziskovalno delo je bilo opravljeno v treh različnih laboratorijih na področju 
mikrobiologije, imunologije in molekularne biologije. Namen magistrske naloge je bil 
določiti strukturo lipopolisaharida in proučiti odziv komplementnega sistema na izbrane 
seve E. coli, izolirane iz črevesne mikrobiote zdravih ljudi, ki so vsebovali različno število 
genov, povezanih z virulenco (VAG) zunajčrevesnih sevov E. coli (ExPEC).  
Postavili smo sledeče hipoteze: 
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- sevi E. coli iz črevesne mikrobiote zdravih posameznikov, ki vsebujejo gene, 
povezane z virulenco, so sposobni aktivirati gostiteljev imunski sistem 
- nekateri sevi E. coli so se sposobni izogniti napadu imunskega sistema z vezavo 
regulatornega faktorja H 
- LPS-profil izbranih sevov korelira z močjo imunskega odziva. 
 
Pri raziskovalnem delu smo uporabili štirinajst fekalnih izolatov sevov E. coli iz zbirke BJ 
(BJ14, BJ16, BJ17, BJ23, BJ27, BJ30, BJ33, BJ34, BJ51, BJ67, BJ69, BJ93, BJ95, BJ97). 
Navedeni sevi E. coli so bili izolirani iz zdravih posameznikov in so del zbirke 90 
komenzalnih sevov BJ na Oddelku za biologijo, Katedra za molekularno genetiko in 
biologijo mikroorganizmov, Biotehniška fakulteta, Univerza v Ljubljani. Različni 
virulentni faktorji, filogenetske skupine, mikrocini in kolicini so bili določeni vsem sevom 
zbirke BJ. Sevi E. coli za raziskavo so bili izbrani glede na število virulentnih dejavnikov, 
da bi predstavljali genotipično različne variante E. coli. V raziskavi smo testirali tudi 
nekatere patogene seve E. coli, bodisi kot kontrolne seve ali za primerjajo jakosti aktivacije 
komplementnega sistema. 
 
Za določitev virulentnega potenciala sevov E. coli smo uporabili metode, s katerimi smo 
pridobili podatke, ki nakazujejo patogenost sevov, in izmerili aktivacijo komplementnega 
sistema. Pri raziskavi smo določili strukturo membrane E. coli sevov (torej LPS profil, 
število različnih O-verig in tip zunanjega dela O-polisaharidne sredice), vezavo 
komplementnega regulatornega faktorja H in odlomka komplementnega sistema C7. 
Kriterij za odziv komplementnega sistema je bil vezava faktorja H in odlomka C7. 
Regulatorni faktor H lahko prepreči aktivacijo komplementa in predstavi bakterijo kot del 
telesu lastne celice. Tako se lahko bakterija izogne delovanju komplementnega sistema. 
Odlomek C7 je ključni faktor, ko se začne vstavitev membranskega kompleksa (MAC) v 
membrano in je del samega membranskega kompleksa, ki povzroči lizo celice s 
porušenjem ionskega in osmotskega ravnotežja. Odlomek C7 torej indicira nastanek 
litičnega kompleksa, zato je bil merilo za aktivacijo komplementnega sistema. Znano je, da 
LPS vpliva na odziv prirojenega imunskega sistema.  
 
Analize LPS so bile narejene na Katedri za molekularno genetiko in biologijo 
mikroorganizmov v Ljubljani. LPS-profile sevov smo določili s poliakrilamidno gelsko 
elektroforezo v prisotnosti natrijevega dodecilsulfata (SDS-PAGE). Pripravili smo dva 
gela: zgoraj gel za nanos, spodaj pa gel za ločevanje. Gele smo postavili vertikalno v 
sistem z elektroforeznim pufrom in priključili na električno napetost. Na koncu smo gele 
pobarvali s srebrom in pogledali z gel-dokumentacijskim sistemom (G:box). Za analizo 
tipa O-polisaharidne sredice s PCR smo pripravili lizate sevov E. coli. Uspešnost priprave 
lizatov smo preverili z metodo ERIC-PCR in produkte analizirali z gelsko elektroforezo. 
Vsi lizati so bili uspešno pripravljeni in primerni za nadaljnje analize s PCR. Sevom smo 
določili O-polisaharidno sredico s specifično metodo PCR in produkte analizirali z gelsko 
elektroforezo.  
 
Analize vezave regulatornega faktorja H in odlomka komplementnega sistema C7 so bile 
izvedene v laboratorijih na Diviziji za higieno in medicinsko mikrobiologijo v Innsbrucku 
in Laboratoriju za pretočno citometrijo v Ljubljani, kjer smo določili tudi viabilnost celic. 
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Analize smo izvedli z monoklonskimi protitelesi in pretočno citometrijo. Signal je bil 
določen kot mediana vrednosti intenzitete fluorescence pripadajočega fluorokroma. 
Uporabili smo metodo indirektne fluorescence z dvema različnima protitelesoma. Primarno 
protitelo je bilo usmerjeno proti faktorju H ali odlomku C7, ki sta bila vezana na 
bakterijski celici. Sekundarno protitelo je bilo detekcijsko protitelo, označeno s 
fluorokromom, ki smo ga vezali na primarno protitelo. Viabilnost celic smo določali s 
kompletom, ki vsebuje barvili tiazoloranž in propidijev jodid. Tiazoloranž obarva žive in 
mrtve celice, propidijev jodid pa samo mrtve celice. Barvili se vežeta na DNA (tudi RNA), 
saj se interkalirata  v dvoverižno strukturo nukleinske kisline. Analize so bile izvedene na 
pretočnih citometrih BD FACSCanto™ II (programska oprema BD FACSDiva) in BD 
FACSVerse™ (programska oprema BD FACSuite), ki sta po značilnostih primerljiva. 
 
V nalogi pridobljene podatke smo statistično obdelali s programom FlowJo in 
Fischerjevim natančnim testom. 
 
Komenzalni sev E. coli BJ33 in laboratorijska seva E. coli MG1655 in E. coli DH5α imajo 
hrapav LPS-profil, torej brez O-antigena. Vsi drugi v nalogi preučevani sevi E. coli imajo 
gladki LPS-profil. LPS-profili se razlikujejo glede na: 
- dolžino LPS-verige (pozicija posamezne lise na gelu) 
- količino določenih LPS-verig pri posamezni dolžini  (debelina lise na gelu) 
- število O-verig z različno dolžino v LPS (število lis na gelu) 
Pri nekaterih sevih so vidni podobni LPS-profili, kot na primer pri parih E. coli sevov BJ16 
in BJ23, BJ27 in BJ30 ter BJ93 in BJ97. 
 
Glede na literaturo so gladki sevi z LPS serum rezistentni, hrapavi sevi brez LPS pa serum 
senzitivni, kar pomeni, da pride do lize pri izpostavitvi serumu (Johnson, 1991). Sklepamo, 
da so celice hrapavih sevov BJ33, MG1655 in DH5α najverjetneje lizirale zaradi delovanja 
seruma oz. napada komplementnega sistema.  
 
Stranske verige na polisaharidnem O-antigenu lahko zaščitijo bakterijske celice z 
aktivacijo komplementa izven senzitivnih membranskih mest na zunanji membrani ali z 
blokado mest za vezavo protiteles. Naslednji faktor, ki vpliva na rezistenco je fluidnost 
membrane, ki je povezana z gladkim lipopolisaharidnim tipom in lahko ščiti pred 
učinkovitim vstavljanjem kompleksa MAC v membrano. Nekateri geni za določene 
virulentne faktorje (traT in iss) lahko preprečijo pravilno delovanje kompleksa MAC, 
četudi le-ta doseže zunanjo membrano (Miajlovic in Smith, 2014; Johnson, 1991). Stopnja 
rezistence je sorazmerna količini lipopolisaharida, ki ga sev vsebuje (Johnson, 1991).  
 
Glede na literaturo večina ExPEC sevov spada v filogenetsko skupino B2 (Boyd in Hartl, 
1998; Picard in sod., 1999; Branger in sod., 2005). V naši raziskavi prav tako večina E. 
coli izolatov spada v filogenetsko skupino B2, razen izolata  BJ14, ki spada v skupino B1, 
in izolatov BJ16 in BJ17, ki spadata v skupino A.  
 
Povezava med filogenetsko skupino in tipom O-sredice je skladna z literaturo (Amor in 
sod., 2000). Sevi, ki spadajo v filogenetsko skupino B2, imajo samo tip sredice R1. Sev 
BJ14 ima sredico R3, sev BJ16 tip K-12 in sev BJ17 tip R2. 
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Z določanjem viabilnosti smo lahko razlikovali med živimi in mrtvimi celicami (izvedeno 
samo z analizami z BDFACSCanto II). Menimo, da je določanje viabilnosti omogočilo 
boljšo kvaliteto raziskave, saj smo s tem lahko izločili drobir in druge nečistoče iz 
analiziranih celic. 
 
Diagram intenzitete vezave odlomka C7 na posamezne seve E. coli je pokazal, da lahko vsi 
komenzalni sevi do določene jakosti aktivirajo komplementni sistem, tudi tipični 
komenzalni sev E. coli SE15 (negativna kontrola). Komenzalna seva BJ14 in BJ16 
aktivirata komplement primerljivo z jakostjo uropatogenega seva UPEC J96, kar prikazuje 
Slika 23. Opazimo lahko tudi pomembno razliko v jakosti aktivacije komplementa med 
dvema uropatogenima sevoma in dvema uroseptičnima sevoma (Slika 23). Podrobna 
analiza aktivacije komplementa je predstavljena v Prilogi D, E, F in G (podatki so bili 
obdelani s programom FlowJo), statistika pa v Prilogi H. Predstavljeni so štirje relevantni 
primeri: E. coli BJ16 z 25 µL NHS (pozitiven), E. coli BJ51 z 25 µL NHS (negativen), E. 
coli BJ33 z 5 µL NHS (pozitiven) in E. coli BJ33 z 25 µL NHS (pozitiven). Če 
analiziramo celice seva E. coli BJ16 (Priloga D) v TO+/SSC kvadrantu (torej žive celice, 
ki jih obarva tiazoloranž)  na vezavo odlomka C7, vidimo močno razliko v jakosti 
fluorescence med negativno kontrolo in vzorcem z NHS, kar potrjuje, da sev veže odlomek 
C7. V C7/PI diagramu pa se celice diagonalno premaknejo k večji fluorescenci na vezavo 
odlomka C7 in barvanjem s PI (večja vezava odlomka C7 torej pomeni slabšo viabilnost 
celic).   
 
Glede na vezavo faktorja H in aktivacijo komplementnega sistema (vezavo odlomka C7) 
lahko preučevane seve razdelimo v štiri kategorije (Preglednica 18): 
 močna vezava faktorja H in šibka vezava odlomka C7 (E. coli sevi BJ17, BJ33, 
BJ93, MG1655 in DH5α označeni z zeleno), 
 močna vezava odlomka C7 in šibka vezava faktorja H (E. coli sevi BJ14, BJ27, 
BJ30, BJ32, BJ34 in BJ69 označeni z modro), 
 približno enaka jakost vezave faktorja H in odlomka C7 (E. coli sevi BJ16 in 
UPEC J96 označeni z zlato), 
 šibka vezava tako faktorja H kot odlomka C7 (E. coli sevi BJ23, BJ51, BJ67, 
BJ93 in BJ95 označeni s sivo). 
Pričakovana je bila obratno sorazmerna povezava med vezavo faktorja H in vezavo 
odlomka C7 oz. aktivacijo komplementnega sistema. Faktor H lahko namreč ščiti celice 
pred aktivacijo komplementa in je sredstvo, s katerim se celice izognejo odzivu 
komplementa. V primerih, kjer imamo približno enako jakost vezave faktorja H in 
odlomka C7, je možno, da je faktor H na nek način neuspešen pri preprečevanju aktivacije 
komplementa. Močna vezava faktorja H je vidna pri sevih BJ17, BJ33 in BJ93, ki ne 
vežejo odlomka C7. Ti sevi bi lahko bili med preučevanimi sevi najbolj uspešni  v 
izogibanju delovanju komplementnega sistema zaradi vezave komplementenga 
regulatornega faktorja H. Nadaljnje raziskave so potrebne za določitev natančnega vpliva 
vezave faktorja H na vezavo odlomka C7 oz. aktivacijo komplementnega sistema. 
 
Sev E. coli NCTC 9001 je bil izbran iz zbirke referenčnih sevov na Diviziji za higieno in 
medicinsko mikrobiologijo v Innsbrucku kot kontrolni sev pri raziskavah vezave faktorja 
H, saj smo pri vpeljevanju metode potrdili, da sev veže komplementni faktor H. E. coli ima 
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zunanji membranski protein OmpX, ki spada v skupino dobro ohranjenih 17‒19 kDa 
velikih proteinov, kot je Rck pri salmoneli, za katerega je bilo dokazano, da veže faktor H 
(Heffernan in sod., 1992; Ho in sod., 2010). Torej bi se lahko komplementni faktor H vezal 
na zunanji membranski protein OmpX v E. coli. V nadaljnjih raziskavah bi bilo smiselno z 
metodo PCR preveriti, ali imajo vsi proučevani sevi prisoten gen OmpX. 
 
Našli nismo nobenih statistično relevantnih povezav med preučevanimi geni in aktivacijo 
komplementnega sistema (Preglednica 17). Nadaljnje raziskave bi morali izvesti na večjem 
številu različnih sevov, da bi ugotovili, če takšne povezave obstajajo. 
 
Serum je pomemben dejavnik pri analizah komplementnega sistema, saj je vir 
komplementnih proteinov in drugih dejavnikov, ki regulirajo imunski sistem. Pričakovali 
smo boljšo aktivacijo komplementnega sistema, če smo uporabili več seruma, kar pa v 
raziskavi nismo potrdili, saj smo pri nekaterih sevih ob dodatku večje količine seruma 
opazili zmanjšano ali enako aktivacijo komplementa. V nadaljnjih raziskavah bi povečali 
število poskusov na posameznem sevi z dodatkom 5 µl in 25 µl NHS.  
 
V magistrski nalogi smo prišli do sledečih zaključkov: 
 Izbrani preučevani sevi E. coli so imeli gladki LPS-profil, razen sevov BJ33, 
MG1655 in DH5α, ki so imeli hrapavi LPS-profil. Lipopolisaharidni profil E. coli 
sevov ni vedno koreliral z jakostjo odziva komplementnega sistema. 
 
 Gladki sevi bakterij so bili odporni proti lizi s komplementom, čeprav jih je 
komplementni sistem zaznal (kar je bilo določeno z vezavo odlomka C7), medtem 
ko so hrapavi sevi bili senzitivni na serum (verjetno so lizirali zaradi delovanja 
komplementa).   
 
 Večina analiziranih sevov E. coli  je imela  zunanjo regijo O-sredice tipa R1. 
 
 E. coli sevi iz črevesne mikrobiote zdravih posameznikov, ki imajo z virulenco 
povezane gene, so bili sposobni aktivirati gostiteljev imunski sistem, natanćneje 
komplementni sistem (določeno z vezavo odlomka C7), tudi do jakosti primerljive 
s patogenimi sevi. 
 
 To je prva raziskava, ki je pokazala različne vezavne sposobnosti komplementnega 
faktorja H pri E. coli sevih.  
 
 Nekateri analizirani sevi E. coli bi se lahko bili sposobni izogniti aktivaciji 
komplementnega sistema z vezavo regulatornega faktorja H. 
 
Potrebne so nadaljnje raziskave na večjem setu bakterijskih sevov E. coli, da bi lahko 
natančneje določili povezave med vezavo regulatornega faktorja H in aktivacijo 
komplementa z vezavo odlomka C7, in viruletnim potencialom E. coli sevov. 
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ANNEXES 
Annex A: The effect of thiazole orange (TO) staining of bacteria in analysis plot in flow 
cytometry (BD FACScanto II). 
Viability staining enabled to discriminate between live and dead cells. The kit contained two 
different stains: thiazole orange (TO) and propidium jodide (PI). The cells moved right on the 
pictogram (higher fluorescence intensity of thiazole orange). 
Priloga A: Vpliv barvanja bakterij s tiazoloranžem na diagram pri pretočni citometriji (BD 
FACScanto II). 
Določanje viabilnosti je omogočilo razlikovanje med živimi in mrtvimi celicami. Komplet je vseboval 
dve različni barvili: tiazoloranž (TO) in propidijev jodid (PI). Celice so se premaknile desno na 
piktogramu (večja intenziteta fluorescence tiazoloranža). 
 
Annex A1: FSC/SSC and TO/SSC diagram of blank sample E. coli BJ16 without TO (single 
experiment). 
Priloga  A1: FSC/SSC in TO/SSC diagram pri blank vzorcu E. coli BJ16 brez TO (posamezen 
eksperiment). 
  
 
Annex A2: FSC/SSC and TO/SSC diagram of blank sample E. coli BJ16 with TO (single 
experiment). 
Priloga A2: FSC/SSC in TO/SSC diagram pri blank vzorcu E. coli BJ16 s TO (posamezen 
eksperiment). 
 
 
 
  
Annex B: Flow cytometry analysis (BD FACScanto II) for E. coli strain BJ51.  
Strain was handled with disinfectant Spor-Klenz (prepared in the laboratory according to 
literature). Thiazole orange stains live and dead cells, whereas propidium jodide only dead cells.  
Priloga B: Analiza s pretočnim citometrom (BD FACScanto II) za sev E. coli BJ51.  
Sev je  bil obdelan z dezinfekcijskim sredstvom Spor-Klenz (pripravljen v laboratoriju po literaturi). 
Tiazoloranž barva mrtve in žive celice, propidium jodid pa samo mrtve.  
 
Annex B1: FSC/SSC and TO/SSC analysis plot for E. coli strain BJ51 (single experiment). 
Strain was handled with disinfectant Spor-Klenz. We can clearly distinguish between impurities 
or debris (red) and the dead cells (green). 
Priloga B1: FSC/SSC in TO/SSC diagram za sev E. coli BJ51 (posamezen eksperiment). 
Sev je bil izpostavljen delovanju dezinfeksicjskega sredstva Spor-Klenz. Med nečistočami ali 
debrisom (rdeča) in mrtvimi celicami (zelena) lahko jasno razlikujemo. 
 
 
Annex B2: PI/count diagram for E. coli strain BJ51 (single experiment). 
The dead cells stained with propidium jodide are represented. The histogram moves far right 
(the fluorescence intensity is higher), therefore those cells are presumed dead. 
Priloga B2: Diagram PI/število za sev E. coli strain BJ51 (posamezen eksperiment). 
Predstavljene so mrtve celice s propidijevim jodidom. Histogram se pomakne daleč na desno (višja 
jakost fluorescence), torej predvidevamo, da so celice mrtve. 
 
 
 
 
 
  
Annex C: FlowJo analysis of the data (BD FACScanto II) of E. coli strains BJ51 (single 
experiment) and HS39 (single experiment). 
Strains were handled with disinfectant Spor-Klenz (left strain BJ51: Q2=32.7% of dead cells; 
right strain HS39: Q2=15.0% of dead cells). Thiazole orange stains live and dead cells, whereas 
propidium jodide only dead cells.  
Priloga C: FlowJo analiza podatkov (BD FACScanto II) E. coli sevov BJ51 (posamezen eksperiment)  
in HS39 (posamezen eksperiment).   
Seva sta bila obdelana z dezinfekcijskim sredstvom Spor-Klenz (levo sev BJ51: Q2=32,7 % mrtvih 
celic; desno sev HS39: Q2=15,0 % mrtvih celic). Tiazoloranž barva mrtve in žive celice, propidium 
jodid pa samo mrtve.  
 
 
 
Detailed analyzes with program FlowJo are presented in Annexes D, E, F and G, 
where four different relevant samples regarding particle C7 binding and the quantity 
of the serum are represented and enable comparing of the results visually and 
statistically: 
 E. coli BJ16 with 25 µL NHS (positive) 
 E. coli BJ51 with 25 µL NHS (negative) 
 E. coli BJ33 with 5 µL NHS (positive) 
 E. coli BJ33 with 25 µL NHS (positive) 
Statistics for those strains is presented in Annex H. Q2 (TO+/PI+) quadrant exhibit 
the strongest fluorescence regarding C7 binding intensity. This quadrant presumably 
represents small percentage of cells that are dead (PI+) because of complement 
attack (C7+). More cells are in Q3 (TO+/PI-) quadrant that also exhibits a strong 
fluorescence, meaning cells bind C7, but are not dead. In negative strains Q1 and Q4 
quadrants (that are TO-) exhibit the strongest fluorescence. If we analyze TO+/SSC 
subset of cells (live cells that are stained with thiazole orange) to C7 binding, a 
strong difference in fluorescence is observed in negative control and sample with 
NHS for C7 positive  E. coli strains, confirming a response to C7 binding and 
activation of the complement system. In C7/PI diagram cells diagonally move to 
higher C7 and PI fluorescence in samples with NHS (therefore, better C7 binding 
means lower viability of the cells). 
 
 
 
  
Annex D: Detailed FlowJo analysis (BD FACScanto II) of E. coli strain BJ16 which is positive 
for C7 binding, exposed to 25 µl of NHS (single experiment). 
Negative controls are on the left, samples with serum are on the right.  
Priloga D: Podrobna FlowJo analiza (BD FACScanto II) seva E. coli BJ16, ki je pozitiven za vezavo 
C7, izpostavljenega 25 µl NHS (posamezen eksperiment). 
Na levi strani so negativne kontrole, na desni pa vzorci s serumom.  
 
 
 
 
  
  
Annex E: Detailed FlowJo analysis (BD FACScanto II) of E. coli strain BJ51 which is negative 
for C7 binding, exposed to 25 µl NHS (single experiment).  
Negative controls are on the left, samples with serum are on the right.  
Priloga E: Podrobna FlowJo analiza (BD FACScanto II) seva E. coli BJ51, ki je negativen za vezavo 
C7, izpostavljenega 25 µl NHS (posamezen eksperiment). 
Na levi strani so negativne kontrole, na desni pa vzorci s serumom.  
 
 
 
 
  
Annex F: Detailed FlowJo analysis (BD FACScanto II) of E. coli strain BJ33 which is positive 
for C7 binding, exposed to 5 µl NHS (single experiment).  
Negative controls are on the left, samples with serum are on the right.  
Priloga F: Podrobna FlowJo analiza (BD FACScanto II) seva E. coli BJ33, ki je pozitiven za vezavo 
C7, izpostavljenega 5 µl NHS (posamezen eksperiment). 
Na levi strani so negativne kontrole, na desni pa vzorci s serumom.  
 
  
  
    
  
  
Annex G: Detailed FlowJo analysis (BD FACScanto II) of E. coli strain BJ33 which is positive 
for C7 binding, exposed to 25 µl NHS (single experiment).  
Negative controls are on the left, samples with serum are on the right.  
Priloga G: Podrobna FlowJo analiza (BD FACScanto II) seva E. coli BJ33, ki je pozitiven za vezavo 
C7, izpostavljenega 25 µl NHS (posamezen eksperiment). 
Na levi strani so negativne kontrole, na desni pa vzorci s serumom.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Annex H: Table with corresponding statistics to Annexes D, E, F and G, where median fluorescence intensities of particle C7 binding are listed (single 
experiment for each strain; FlowJo, LLC, v10.4.2). 
Priloga H: Preglednica s pripadajočo statistiko k prilogam D, E, F in G, kjer so navedene mediane intenzitete fluorescence za vezavo odlomka C7 (posamezen eksperiment 
za vsak sev; FlowJo, LLC, v10.4.2). 
 
 
 
 
 
 
E. coli BJ16 E. coli BJ51 E. coli BJ33  E. coli BJ33 
(25 µL NHS) (25 µL NHS) (5 µL NHS) (25 µL NHS) 
Median fluorescence 
intensity to C7 
Negative 
control 
Sample with 
NHS 
Negative 
control 
Sample with 
NHS 
Negative 
control 
Sample with 
NHS 
Negative 
control 
Sample with 
NHS 
Q1 32,5 246,0 26,0 298,0 22,5 104,0 25,7 111,0 
Q2 3,0 376,0 29,8 65,7 3,0 460,0 14,1 3686,0 
Q3 3,0 234,0 3,0 5,0 3,0 11,3 -2,6 123,0 
Q4 3,0 113,0 3,0 378,0 3,0 36,2 3,9 136,0 
TO+ SSC subset 
median fluorescence 
intensity to C7 
3,0 241,0 3,0 8,7 3,0 40,0 -1,3 191,0 
